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ABSTRACT
Drug-Related Mortality:
Postmortem Findings in 
Clark County, Nevada 
For 2005
By
Melanie Lee Gulmatico
Dr. Chad L. Cross, Examination Committee Chair 
Associate Professor of Biostatistics 
University of Nevada, Las Vegas
Drugs, such as Cannibis, alcohol, cocaine and prescription medications can have 
deleterious effects on the body. This thesis analyzed toxicology results in relation to 
modes of death, and discusses who is at risk for deaths related to drug abuse. The modes 
of death studied were homicides, suicides, accidents, and natural causes. Data (N=2426) 
from Clark County, Nevada’s Coroner’s office were statistically analyzed using Chi- 
square analysis.
Major findings included relationships between drugs, ethnicity, age, gender and mode 
of death. Opioids and morphine derivatives were the most common drugs found in 
Caucasians, females and those who died of natural and accident-related deaths. 
Homicides were most commonly associated with ethanol and stimulants. The prevalence 
of ethanol was also most common within African Americans, Hispanics, Asians, males, 
high school aged decedents and in suicides. The purpose of this study is to inform the 
public and public health professionals of the associations found with drugs and death.
Ill
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CHAPTER 1 
INTRODUCTION
Clark County, Nevada is home to Las Vegas, one of the fastest growing cities in the 
nation (Research Applications, Inc., 2003). Along with this rapid population growth, 
greater numbers of people in Clark County are dying every year. In 2005 over 10,000 
deaths were reported to the Clark County Coroner’s Office (Clark County Coroner’s 
Office). Of the deaths that were investigated, toxicological findings were recorded; they 
include a variety of drugs commonly found on the streets, prescribed or accessible over- 
the-counter
Drugs can be either misused or abused. The difference between the two is that when 
one misuses a drug, they are practicing inappropriate use of prescription or 
nonprescription drugs (Levinthal, 2005). Such drugs are misused when dosages are 
increased beyond the level prescribed, or when dangerously mixed with alcohol or other 
drugs that affect the nervous system (Inaba & Cohen, 2004). The abuse of a drug applies 
to when one utilizes a licit or illicit drug, “in ways that produce some form of physical, 
mental, or social impairment” (Levinthal, 1999, p.6). Drugs which are commonly abused 
involve not only common street drug such as cocaine or heroin, but also involve legal 
psyehoactives such as caffeine, nicotine, alcohol and inhaled solvents (Inaba & Cohen, 
2004). Prescription drugs are also being abused for purposes non-medicinal. Recreational 
prescription drug use is often found in adolescents, teens, college students, adults and the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
elderly (Compton & Voikow, 2005; Kolek, 2006). Prescription drugs such as oxycodone, 
hydrocodone, methadone and morphine are now being used recreationally. (Compton & 
Volkow, 2005). Although illicit drugs such as cocaine and heroin are extremely 
dangerous and potentially fatal, the danger of recreational misuse with prescription 
medications can also lead to a deadly overdose.
Four different modes of death, namely, natural, aeeident, suicides and homicides were 
studied and the statistics of postmortem toxicological findings were examined. Ethnicity, 
age and sex were also studied to see who was at greatest risk for drug-related deaths.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2
LITERATURE REVIEW
The drugs discussed in this section can be classified into five different levels or 
schedules. Inaba & Cohen (2004) suggest that by controlling the manufacture, sale and 
use of psychoactive drugs, the imports and exports of such drugs can be limited and 
criminal penalties can be defined. Table 1 shows a list and description of the five drug 
schedules.
Drug Categories
The drugs detected have been classified into 11 different categories by 
The National Institute on Drug Abuse (NIDA): Antidepressants, prescription 
medications, depressants, analgesics, dissociative anesthetics, cannabinoids, opioids and 
morphine derivatives, stimulants, anabolic steroids, inhalants and over-the-counter 
medications.
* Antidepressants
Over 17 million Americans a year are affected by depression, which results in 
sadness, loss of pleasure and a decline in the capacity and willingness to enjoy life 
(Levine, 1999; Levinthal, 2005). First generation antidepressants were found by accident 
and were originally used for treatment of tuberculosis (Levinthal, 2005). After realizing
* See Appendix I for common names, brand names, street names and molecular 
structures.
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patients were in better spirits, antidepressants started being prescribed for depression 
(Inaba & Cohen, 2004; Levinthal, 2005). Owing to the fact that these drugs help people 
feel good and overcome depression would lead one to believe that prescription overdose 
in relation to these drugs may be problematic.
Table 1 Drug Schedules
Schedule Description Examples
I High abuse potential and 
supposedly no accepted 
medical use
Narcotics such as: Heroin, 
LD, marijuana, peyote, 
psilocybin, mescaline, and 
MDMA
II High abuse potential with 
severe psychic or physical 
dependence liability even 
though there are medical 
uses for the drugs
Narcotics such as: Cocaine, 
methamphetamine, opium, 
morphine, hydromorphone, 
codeine, meperidine, 
oxycodone, methylphenidate 
(Ritalin®)
III Less abuse potential and 
include schedule II drugs 
when used in compounds 
with other drugs
Prescription drugs such as: 
Tylenol®, with codeine, 
some barbiturate 
compounds, and paregoric
IV Even less abuse potential Depressants such as: chloral 
hydrate, meprobamate, 
fenfluramine, diazepam 
(Valium®), other 
benzodiazepines and 
phénobarbital
V Very low abuse potential 
because they contain 
limited quantities of 
narcotic and stimulant 
drugs
Over the counters such as: 
Robitussin AC® (DXM), 
Lomotil®
Information for table adapted from Drug Enforcement Agency website; www.usdoj.gov 
retrieved on August 25,2006
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Monoamine oxidase (MAO) is the key enzyme inhibited by first-generation 
antidepressants (Levine, 1999; Levinthal, 2005). Although MAO inhibitors are 
beneficial in treating depression, hindering this enzyme has detrimental effects on the 
liver (Levinthal, 2005). MAO functions in the liver by helping break down the chemical 
tyramine. If MAO is inhibited, high levels of tyramine will accumulate and potentially 
increase the chance of having a stroke (Levinthal, 2005). Therefore, there are strict 
dietary considerations when taking these medications (Kent, 2000).
Tricyclic antidepressants (TCAs) are another class of first-generation antidepressants 
(Levine, 1999; Levinthal, 2005). Chemically, their structure contains three-rings, hence 
the name tricyclic (Levinthal, 2005). They inhibit the reuptake of serotonin or 
norepinepherine, or both, and have been found to be among the leading causes of drug- 
related deaths in the world because of their high toxicity (Levine, 1999). However, 
because TCAs do not inhibit MAO, they are generally safer than the first generation . 
MAO inhibitors (Levinthal, 2005).
The pharmacologic action of second-generation antidepressants also inhibits the 
reuptake of serotonin or norepinepherine or both neurotransmitters associated with mood 
(Levine, 1999; Inaba & Cohen, 2004). These antidepressants increase the amount of 
serotonin distributed throughout the nervous system, and hence are called serotonin 
selective reuptake inhibitors (SSRIs) (Inaba & Cohen, 2004). Thus, by this action, they 
correct the imbalance of serotonin. SSRIs are the most commonly prescribed group of 
antidepressants and are also used in treating obsessive-compulsive disorder and bulimia 
(Levine, 1999). SSRIs are more commonly prescribed than TCAs and have fewer 
troublesome side effects. They also lack the cardiovascular toxicity associated with TCAs
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Levine, 1999). The most recognized SSRI antidepressant is fluoxetine (brand name, 
Prozac®). It was introduced in 1987 and aside from having few side effects it is also safe 
for patients with cardiovascular problems (Levinthal, 2005). Thus, it can be used in place 
of the tricyclic antidepressants mentioned above.
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) are a newer class of 
antidepressants, which have lower side effects than SSRIs, yet are effieient in treating 
mood disorders and generalized anxiety disorders (Mattia, Paoletti, Coluzzi, & Boanelli, 
2002). The newest and most studied antidepressant of this class is Venlafaxine (brand 
name, Effexor®), which is advantageous in its effectiveness in treating pain (Kent, 2000). 
An interesting therapeutic result of Venlafaxine is that it has the capacity to act as either a 
SSRI at low dosages or a TCA at high dosages (Mattia et al., 2002; Kent, 2000).
Depressants
Depressants (“downers”) affect individuals by reducing the activity of the brain, or by 
inducing sedation, muscle relaxation and drowsiness (Levine, 1999; Inaba & Cohen,
2004). They are often used for those who feel immense stress and to help reduce anxieties 
and problems encountered on a daily basis (Levinthal, 2005).
Barbiturates, benzodiazepines, meprobamate, buspirone, and zolpidem are a few of 
the common central nervous system (CNS) depressants available today (Levine, 1999). 
Barbiturates are one of the oldest classes of depressants and were first synthesized in 
1863 (Inaba & Cohen, 2004; Levine, 1999). They may be used during the induetion of 
surgical anesthesia, to induce coma, as sedative-hypnotic agents, to control seizures or for
See Appendix II for common names, brand names, street names and molecular 
structures.
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the relief of intracranial pressure in patients with head trauma (Inaba & Cohen, 2004; 
Levine, 1999).
Benzodiazepines represent the other major class of CNS-depressant drugs. They 
absorb slowly into the bloodstream, making their effects longer lasting than barbiturates 
(Levinthal, 2005). Benzodiazepines also have a lower fat-solubility, greater water- 
solubility and are absorbed from the small intestine instead of the stomach like 
barbiturates (Levinthal, 2005). They have been approved for use in people with 
obsessive-compulsive disorders, as anxiolytics, muscle relaxants, anesthetic adjuncts, and 
anticonvulsants (Levine, 1999). The safety of benzodiazepines is the major advantage of 
these drugs. They have fewer side effects and lower withdrawal symptoms than 
harbiturates; however, they are often abused concomitantly with methamphetamine, 
cocaine or even heroin (Inaba & Cohen, 2004; Levine, 1999).
Studies have found that alcohol is one of the most commonly abused depressants, and 
in fact it is estimated that annually over 2 million people die worldwide owing to alcohol 
(Inaba & Cohen, 2004). Numerous physiological effects are associated with alcohol 
consumption, such as gastric irritation, liver disease, cardiovascular effects, sleeping 
problems and pregnancy defects (Levinthal, 2005). Not only does alcohol have 
detrimental effects on the body, but it has been found that the relationship of alcohol, 
drugs and violence has grown tremendously (Parker & Auerhahn, 1998). Studies have 
shown that violent acts are overwhelmingly associated with alcohol use, more than any 
other illieit or non-illicit substance (Parker & Auerhahn, 1998). Alcohol abuse and its 
relation to violence, suicide and death will be discussed in greater detail in later sections.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Assuming many people use depressants in order to run away from the many ordeals 
and ehallenges life brings, would also lead one to believe that overdoses in these drugs 
may potentially be a problem in relation to death.
Ŝtimulants
Stimulants are preseribed for disorders such as narcolepsy, attention defieit disorder 
and obesity (Inaba & Cohen, 2004). However, the fact that stimulants trigger the 
reward/reinforcement center of the brain makes addiction to theses drugs problematic 
(Inaba & Cohen, 2004). Misuse of stimulants continues to be a problem, and in 2002 a 
survey found that more than a third of the American population admitted to misusing 
Attention-Defieit/Hyperaetiviy Disorder (ADHD) stimulants in their lifetime (Kroutil, 
Van Brunt, Herman-Stahl, Heller, Bray, & Penne, 2006).
Unlike depressants, stimulants (“uppers”) increase the chemical and electrical activity 
in the central nervous system (Inaba & Cohen, 2004). They make the user more alert, 
cause feelings of intense pleasure, and feelings of increased energy after being taken 
(Inaba & Cohen; Levine, 1999). The most commonly used stimulants are amphetamines 
and methamphetamines (Levine, 1999). Manipulating the neurotransmitters epinephrine 
and norepinephrine, stimulants force the release of these energy chemicals giving the 
body bursts of energy (Inaba & Cohen, 2004).
Limited to disorders such as obesity, narcolepsy and attention deficit disorder, 
prescription of psychostimulants can have serious side effects. Fenproporex, a drug used 
for treatment of obesity, and modafmil, used for treatment of sleep and concentration 
disorders, have been found to be extremely dangerous (Pelissier-Alicot, Piereecehi-Marti,
* See Appendix III for common names, brand names, street names and molecular 
structures.
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Bartoli, Kuhlmann, Coiffait, Sanvosisin, Giocanti, & Leonetti, 2006). A study by Peliser- 
Alicot et al. (2006) showed that fenproporex is incredibly addictive, and therefore it was 
withdrawn from the market in 1999 because of lack of efficacy relating to obesity 
management. However, this drug is still available on the Internet, thereby potentially 
causing serious public health issues (Pelissier-Alicot et al., 2006). Modafinil was found to 
have side effects including agitation, aggressive behavior and anorexia. As a central 
nervous system stimulant, it has been used to treat ADHD in children 6 years of age and 
older. Other side effects are insomnia and dependence therefore restricting Modafinil to a 
maximum of 28 days (Pelissier-Alicot et al., 2006). Along with Modafinil, drugs such as 
Ritalin, Dexedrine, Adderall and Cylert are all used for treatment of ADHD (Inaba & 
Cohen, 2004). Of the children treated with these drugs, about 75% have effectively 
controlled hyperactivity (Inaba & Cohen, 2004). Furthermore, easy accessibility of 
prescription stimulants can lead to overdose or death if misused or abused.
Opioids and Morphine Derivatives
Opioids are alkaloid analgesics, which occur naturally in the opium poppy, Papaver 
somniferum (Levine, 1999). The plant grows three to four feet high and its flowers are 
about four or five inches in diameter. The flowers vary in color (white, pink, red or 
purple) and the pods of these flowers contain opium (Levinthal, 2005). Clinically, opioids 
are used in postoperative analgesia and also have therapeutic uses for pain management 
in cancer and terminal illnesses (Levine, 1999).
Opium poppies were first used in Egypt and Greece, and then spread to Asia (Inaba & 
Cohen, 2004). They were utilized for illness, as pleasure-inducing substances and as
See Appendix IV for common names, brand names, street names and molecular 
structures.
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poisons (Inaba & Cohen, 2004). After opium use spread to the United States it was 
utilized more by women than men because of the stigma towards women at the time 
(Levinthal, 2005). Because alcohol use was not accepted with women, it was no surprise 
to find men drinking alcohol in the saloon while women took opium at home during the 
1940s (Levinthal, 2005). Opium smoking was introduced to the western US by Chinese, 
who used it as a painkiller and for diarrhea treatment (Levinthal, 2005).
Morphine and codeine are extracts that come naturally from the unripe seed pod. 
(Levine, 1999; Inaba & Cohen, 2004). Heroin, hydromorphone, hydrocodone and 
oxycodone are semisynthetic opiates synthesized from morphine (Levine, 1999; Inaba & 
Cohen, 2004). Methadone, meperidine and propoxyphene are fully synthetic opiate-like 
drugs (Inaba & Cohen, 2004).
* Analgesics
Analgesics include nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, 
ibuprofen, naproxen sodium and acetaminophen. They are most commonly found in 
groceries and pharmacies (Levinthal, 2005). Although NSAIDs are most commonly 
found as over-the-counter medications, they are also prescribed for arthritic pain. 
Celebrex is one popular brand of prescription NSAID (Levinthal, 2005). Analgesics, 
commonly used by athletes, help reduce inflammation and deaden pain (Inaba & Cohen, 
2004; Levinthal, 2005). Athletes often take analgesics to mask pain, which can 
furthermore aggravate injury (Inaba & Cohen, 2004).
The analgesic compound salicylic acid was the first NSAID used to treat pain in the 
19* century; however, it was extremely irritating to the digestive tract (Levinthal, 2005).
See Appendix V for common names, brand names, street names and molecular 
structures
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Years later a chemist manipulated salicylic acid by adding an acetyl group in order to 
lessen its toxicity. Because it was derived from spirea plants, salicylic acid was named 
“aspirin.” It can be used to reduce inflammation, for mild pain such as headaches and 
also to lower elevated body temperature (Levinthal, 2005). While opioids such as 
morphine or hydrocodone work on the central nervous system, aspirin works by blocking 
synthesis of hormones called prostaglandins via inhibition of cyclooxygenase (Hawkey, 
1999; Levinthal, 2005). When injury occurs, prostaglandins encourage inflammation in 
the joints and act on the hypothalamus of the brain, increasing body temperature. Thus, 
aspirin is a helpful therapeutic drug in treating such ailments. Unfortunately, 
physiological effects such as gastric bleeding, a reduction in blood clotting and Reye’s 
syndrome may occur in children who are using aspirin for infections such as chicken pox 
(Levinthal, 2005).
Ibuprofen is also used to lower body temperature, reduce pain or inflammation and 
for menstrual cramps. As with aspirin, Ibuprofen has the same method of action in 
blocking the production of prostaglandins (Levinthal, 2005). However, ibuprofen causes 
less gastric irritation than aspirin, but may also cause kidney damage or failure 
(Levinthal, 2005). Acetaminophen is also a popular over-the-counter analgesic, which is 
used for pain and inflammation. It is less toxic on the stomach and does not interfere with 
the clotting processes (Levinthal, 2005). A problem arising from usage of acetaminophen 
is liver damage, espeeially if eombined with aleohol (Levinthal, 2005). After this was 
discovered, the FDA recommended warnings on the labels to advise users of such 
toxicity (Levinthal, 2005).
11
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Prescription Medications 
Prescription drugs may be purchased after licensed physicians or other licensed health 
professionals have certified utilization for a medical condition requiring such drugs 
(Levinthal, 2005). In 2002 approximately $154.5 billion was spent on prescription 
medications in America (Inaba & Cohen, 2004). The top ten leading brands of 
prescription drugs include: Lipitor, Prevaeid, Prilocec, Zoeor, Celebrex, Zoloft, Paxil, 
Zyprexa, Norvac and Nexium (Levinthal, 2005). After approval from the Food and Drug 
Administration (FDA), prescription drugs are dispersed to a large population of patients. 
Safety, effectiveness, and levels of dosage are finalized through the FDA (Levinthal,
2005). Although the FDA approves the distribution of prescription drugs, their safety is 
only guaranteed if  taken at recommended dosage (Levinthal, 2005). Thus, it is common 
sense that the abuse of prescription drugs may be dangerous.
**Over-the-Counter Drugs 
Over-the-counter drugs are available to the public without a prescription and have 
potential of misuse. Analgesics, sleep aids, and cough-and-cold remedies all can be 
bought without the supervision of a physician (Levinthal, 2005). Corticosteroids are also 
popular drugs found over-the-counter, and are used to control inflammation and pain 
(Inaba & Cohen, 2004). Although easily accessible, NSAIDs can produce serious 
problems if abused (Levinthal, 2005).
Over-the-counter drugs such as cough/cold preparations, analgesics and vitamins also 
can be harmful to children (Chien, Marriott, Ashby, & Ozanne-Smith, 2003). The fact
* See Appendix VI for common names, brand names, street names and molecular 
structures
"See Appendix VI for common names, brand names, street names and molecular 
structures
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that they are widely available in homes, and stored in easily accessible cabinets and 
cupboards, places children at a higher risk for overdose (Chien et al., 2003).
Dissociative Anesthetics 
Dissociative anesthetics can be classified as hallucinogens, which produce feelings of 
being dissociated or separated from oneself and the environment (Levinthal, 2005). The 
most notorious of this drug category is called phencyclidine (PCP) and causes not only 
hallucinogenic effects, but also stimulant and depressant effects (Levinthal, 2005). A 
common street name for PCP is “angel dust” because of the powdered form; liquid PCP 
is sometimes mixed with marijuana (“sherm”) and smoked in order to enhance the effects 
of marijuana (Levinthal, 2005, Inaba & Cohen, 2004). Initially phencyclidine was used 
clinically as an anesthetic or analgesic in humans until adverse psychological reactions 
were observed (Levine, 1999). It was also used as a tranquilizer for large-animals, yet the 
legal manufacture of PCP discontinued in 1979 (Levine, 1999). Behavioral and 
psychological effects resulting from use of phencyelidine are perceptual distortions, 
feelings of power and strength, disorientation, agitation, aggressive behavior and amnesia 
(Levine, 1999; Levinthal, 2005). Other hallucinogenic drugs consist of LSD, psilocybin 
“shrooms”, and peyote buds (Inaba & Cohen, 2004).
*Cannabinoids
Cannabinoids are found in numerous species of the Cannabis plant, the most eommon 
of which is C. Sativa (Levine, 1999). They are found in the resin that aceumulates on the 
leaves and stems of this plant (Levinthal, 2005). It originated in Central Asia and was
See Appendix VII for common names, brand names, street names and molecular 
structures
** See Appendix VIII for common names, brand names, street names and moleeular 
structures
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used therapeutically for relief of pain, muscle spasms, convulsions, epilepsy, asthma, and 
rheumatism (Levine, 1999). In 1910, cannabis was introduced to the United States and 
continues to be the most commonly used drug (Levine, 1999). Interestingly, it is 
classified by the Drug Enforcement Agency (DEA) as having no accepted medical uses 
for any disease because other medications are available that are more effective (retrieved 
from: http://www.usdoj.gov/dea/ongoing/marijuanap.html on August 2, 2006).
The primary psycho active agent in the Cannabis sativa plant is delta-9- 
tetrahydrocannabinol (THC) (Levinthal, 2005; Levine, 1999). Several different 
substances contain THC; these are marijuana, hashish, hash oil, and prescription Marinol, 
which can produce hallucinogenic or a ‘pleasurable high’ depending on the dose (Levine, 
1999). Marijuana is the most common psychoactive drug originating from the cannabis 
plant, which contains different THC concentrations (Levinthal, 2005). Feelings of 
euphoria and well being as well as sharpened sense of sight and sound are all 
psychological and behavioral effects that have been reported with marijuana’s 
intoxicating characteristics (Levinthal, 2005).
Anabolic Steroids
Anabolic steroids are used to promote the synthesis of proteins in the body, which in 
turn increase muscular development and masculine characteristics (Inaba & Cohen, 2004; 
Levinthal, 2005). The promotion of secondary male sexual characteristics is called an 
androgenic effect while the acceleration of muscle growth is an anabolic effect (Karch, 
2002).
See Appendix IX for common names, brand names, street names and molecular 
structures
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Before World War II, anabolic steroids were used to promote healing, speed recovery 
time, and treat depression (Karch, 2002). They are popular with athletes because they are 
believed to improve performance and strength (Karch, 2002). Derived from the male 
hormone testosterone, steroids are clinically used to treat testosterone insufficiency, 
osteoporosis and some breast cancers (Inaba & Cohen, 2004). Although they are 
sometimes used to enhance personal appearance, when misused they can produce 
undesirable effects such as feminization in males and masculinization in females (Inaba 
& Cohen, 2005).
Inhalants
Inhalants consist of volatile organic solvents, hydrocarbon gases, anesthetic gasses 
and nitrites (Levine, 1999). Inhalants are sometimes classified as deliriants, producing 
feelings of euphoria. They are similar to aleohol in that they depress the central nervous 
system (Inaba & Cohen, 2004; Levine, 1999). They can be inhaled through the nose 
and/or mouth, or even smoked after being heated or burned like tobacco and heroin 
(Inaba & Cohen, 2004). Differences between inhalants and other psychoaetive drugs is 
that they are quick acting, yet have intense effects and are readily available and 
inexpensive (present in the home, garage and workplace). However, they do not get the 
attention from media, educators or parents like illieit drugs such as phencyclidine (Inaba 
& Cohen, 2004). Formaldehyde is often used as an inhalant for its depressant and 
psychedelic effect. Marijuana joints are sometimes soaked in formaldehyde (“fi-ysticks”) 
resulting in visual and auditory hallucinations, pain tolerance and feelings of being 
invincible (Levinthal, 2005, NIDA, 2004). Unfortunately, inhalants can cause permanent
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damage to the liver, kidney, lungs and the CNS after just a short period of use (Inaba & 
Cohen, 2004).
Other Compounds
In this study, other compounds consisted of substances such as caffeine, arsenic, 
carbon monoxide, cyanide, mercury and lead. Although these compounds were found in 
a select number of individuals, this paper focuses on the 11 drug categories discussed 
above and will not go into great detail on the use of these compounds relating to death.
Socioeconomic Class, Age, Gender and Drug Abuse 
Socioeconomic class, age and gender all play roles in the types of drugs that are 
abused and potentially lead to fatalities. Blumstein (1995) suggests that there is a higher 
correlation between the illicit drug market and rates of lethal violence among Blacks 
compared to Whites. This conclusion was drawn because of the fact that crack cocaine 
market transactions were more common in impoverished, predominantly African 
American communities (Blumstein, 1995). On the contrary the less dangerous and private 
settings were correlated with a more expensive form of the drug (powder cocaine). These 
transactions were more likely to occur in predominantly White eommunities.
Furthermore, Blumstein (1995) suggests that because the drug trade in predominantly 
Black ghetto communities is highly correlated to a more hostile environment, it would be 
reasonable to conclude that there is a link between drug-market activity and homicide 
within these communities. However, Kilpatrick, Aciemo, Saunders, Resnick and Best 
(2000), found that when controlling effects of demographics, victimization history and
* See Appendix X for common names, brand names, street names and molecular 
structures
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familial substance use, Caucasian adolescents were between three to nine times more 
likely to be at risk for substance abuse and dependence as opposed to African Americans.
A study conducted by Ousey and Lee (2004) found that there is a positive relationship 
between Black cocaine/opiate distribution arrest rate and Black homicide rate. However, 
the same relationship was found with the White drug market and White homicide rate. 
Thus, it was found that cities having high arrest rates associated with an increasing drug 
market also exhibit a high rate of homicide, regardless of ethnicity (Ousey & Lee, 2004).
The University of Maryland at College Park studied the risks associated with 
adolescent substance abuse (Gottfredson & Koper, 1996). Findings suggested that social 
integration, self-esteem, and self-efficacy all have low predictive validity (Gottfredson & 
Koper, 1996). Positive peer influence does not affect black adolescents, yet decreases the 
prevalence of drug use for Whites. Furthermore, drug use is more likely found in female 
adolescents than for males, regardless of ethnicity. Peer influence predominantly affects 
White adolescents and drug use is more strongly predicted for White male adolescents in 
relation to rebellious behavior (Gottfredson & Koper, 1996).
In a study conducted by the National Household Survey of Drug Abuse in 1997, 
marijuana use was highest among people between the ages of 18 and 24 at 22%, while 
cocaine use was found in 4% of this group (Kilpatrick et al., 2000). Using data from the 
National Health Interview Survey between 1987-1990 and the National Death Index data 
through 1991, Kalian (1998) found that Males, Blacks, and Hispanics were identified as 
high-risk subgroups for drug-related mortality. Males had a higher death rate than 
females for fatalities owing to cocaine, or opiate abuse. Cocaine-related deaths were 
higher for Black than Whites or Hispanics. Socioeconomic status also played a role in
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higher mortality rates for Blacks and Hispanics (Kalian, 1998). Violence has been 
suggested to a play a role in not only adolescent, but also adult substance abuse as well 
(Kilpatrick et al., 2000). Those substance abusers who were victimized at one point in 
their lives were found to have started using drugs at a younger age than those who were 
not victimized. Moreover, substance abuse has been found to be a way for adolescents 
and adults to cope with stressors such as interpersonal aggression, whether it results from 
sexual abuse or physical violence (Kilpatrick et al., 2000).
Specific Drugs and Fatalities
Research investigating the connection between the use of drugs and crime suggests 
that there was a spike in violent crime when the craek-cocaine market emerged during the 
1980s (Varano, McCluskey, Pat chin, & Bynun, 2004). Studies found a correlation 
between poor-young-minority men and serious violent crimes during the late 1980s and 
early 1990s (Varano et ah, 2004). In 1998 the Drug Abuse Monitoring Program (ADAM) 
found that the majority of adult male arrestees were positive for cocaine use (Varano et 
ah, 2004). Both marijuana and cocaine have been reported as drugs related to violence 
(Varano et ah, 2004).
When looking at the involvement of drug circumstances in homicide events, research 
shows that over half of all homicides potentially involve drugs (Varano et ah, 2004). 
Research conducted on 800 homicide cases across the United States found that nearly a 
quarter of these eases involved drugs (Varano et ah, 2004). Among homicide victims 
killed in Bexar County, Texas 63% were positive for ethyl alcohol. Within these cases 
alcohol and cocaine were found in abundance with alcohol being detected in more than
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half of the victims (Garriott, DiMaio, & Rodriguez, 1986). People associated with the 
drug market, whether it be abusing or selling, have been found to be involved in violent 
disputes and homicides (Ousey & Lee, 2004).
A study conducted in Bexar County, Texas found a high correlation of drugs and/or 
alcohol in homicide victims during the years of 1985, 1986, 1990 and 1991. The 
concentrations ranged between 66% and 73% (Garriott, 1993). Although heroin 
metabolites were detected in only a small amount of these cases, cocaine increased to 
18.7% by 1991 from 1.6% of cases in 1985. A metabolic byproduct of the combination of 
cocaine and alcohol, coeaethylene, was measured as well during these years. It was found 
that 58% of those who were positive for cocaine and alcohol also had concentration of 
coeaethylene, which is possibly more toxic than cocaine alone (Garriott, 1993). 
Furthermore, coeaethylene has been linked to increased rates of violent behavior (Inaba 
& Cohen, 2004). Among other drugs found in homicide victims were phénobarbital, 
benzodiazepines, diazepam, propoxyphene and antihistamines. Although found in fewer 
numbers of eases, methadone and antidepressants were also identified in homicide 
victims (Garriott, 1993).
Alcohol and Crime
Increases in aggression have been found with consumption of alcohol because it 
interferes with the main inhibitory neurotransmitter, gamma amino butyric acid (GABA). 
(Inaba &Cohen, 2004). Impulse control may also be inhibited due to decreases in the 
levels of serotonin (Inaba &Cohen, 2004). When looking at violent crime, Inaba & Cohen 
(2004) state that, “About one-fourth of the 11.1 million victims of violent crime report 
that the offender had been drinking alcohol prior to committing the crime” (p. 207).
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Studies have found that when one is provoked and under the influence of alcohol, 
aggression leading to violence may occur (Bushman, 1997; Lipsey, Wilson, Cohen, & 
Derzon, 1997). It is known that alcohol causes reduced intellectual functioning, reduced 
self-awareness, selective disinhibition, and inaccurate assessment of risks, it is highly 
likely that violence may result when one is under the influence (Chermaek & Giancola 
1997; Ito, Miller, Pollock, 1996; Parker & Auerhahn 1998). This may further lead to 
one’s involvement in aggression and homicide.
Alcohol and Suicide
As alcoholics age, they are more likely to have social, health and interpersonal 
problems. Thus, their risk for suicide increases (Inaba & Cohen, 2004). Furthermore, 
along with increased age, suicide rates among alcoholics are twice as high than that of the 
general population. The typical aleohol-suicide victim is a white, middle aged, male 
(Inaba & Cohen, 2004). Depression, loss of job, living alone and poor social support are 
other potential risk factors associated with suicide (Inaba & Cohen, 2004).
Overdose
As defined by the Office of National Statistics, drug related deaths may result from 
long-term substance abusers, or occasional recreational users. Drugs involved may be 
prescribed, controlled, or a mixture of both, and death may result from long-term use, 
direct or long term effects. Furthermore, the deceased may die accidentally, through 
suicide, or even homicide (Christophersen, Rooney, & Kelly, 1998).
Alcoholic overdose results from large amounts o f alcohol, such as a blood alcohol 
content (BAC) at a level o f 0.40 (Inaba & Cohen, 2004). When this poisoning occurs, 
depression of the central nervous system results, which may furthermore lead to death
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(Inaba & Cohen, 2004). Although a 0.40 BAC has been noted as the threshold for alcohol 
poisoning, levels at 0.20 or greater can depress respiration and lead to death in those with 
low tolerance levels (Inaba & Cohen, 2004).
Opioid users, such as those who abuse heroin, are likely to experience toxic 
overdoses (Inaba & Cohen, 2004). When looking at the number of people who use 
oxycodone, oxycontin and other opioids, the risk of overdose owing to these types of 
drugs is no surprise. Heroin overdose occurs when blood pressure drops and the lungs fill 
with fluid, causing the victim to experience cardiac arrhythmias and convulsions, which 
may lead to severe respiratory depression and death (Inaba & Cohen, 2004).
Motor Vehicle Fatalities
One of the major causes of mortality, motor vehicle accidents, kills around 300,000 
people in the world every year. Alcohol, prescription drugs and illicit drugs can be 
correlated to many of these unfortunate motor vehicle fatalities (Kelly, Darke, & Ross, 
2004).
Alcohol
Alcohol is the most common psyehoaetive substance found in the blood of victims 
involved in motor vehicle crashes (Bates & Blakely, 1999). It reduces motor coordination 
as well as alertness and depth perception. In order to drive safely, one must be alert and 
able to make fast decisions in order to compensate for unexpected driving conditions and 
situations. Alcohol, as a depressant drug, slows your brain and body, which can limit 
awareness and coordination (Levine, 1999). Overconfidence is a common effect after 
consumption of alcohol, which can alter judgment and driving skills (Levine, 1999).
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Among motor vehicle drivers killed in Bexar County, Texas, 55% of the drivers were 
positive for ethyl alcohol (Garriott et al., 1986). Laboratory studies, simulator and driving 
studies have all confirmed that performance after drinking alcohol increases deficits in 
concentration, coordination, speed control, lane control, and brake reaction time (Kelly et 
ah, 2004). Depending on their blood alcohol concentration, Christophersen et al. (1999) 
found that accident risk can be anywhere from four to twelve times greater than those 
who drive without being intoxicated.
Cannabis
Cannabis may affect short-term psyehomotor and cognitive effects in an individual 
(Bates & Blakely, 1999). These effects not only alter perception and memory, but also 
impair motor coordination tests (Inaba & Cohen, 2004). Psychomotor effects of Cannabis 
use have been studied and it was found that following distance increased while driving 
and that when Cannabis was mixed with alcohol, driving performance was affected 
(Bates & Blakely, 1999). Cannabis is the second most frequent drug detected in motor 
vehicle crashes (Bates & Blakely, 1999). In 1985, a study in Bexar County,Texas found 
that approximately 50% of homicide and motor vehicle victims were tested positive for 
the presence of eannabinoids (Garriott et al., 1986). When looking at epidemiological 
studies examining the incidence of drug use in traffic collisions, between 2.7% and 
13.9% of drivers tested positive for eannabinoids (Soderstrom, Dischinger, Kerns, & 
Trifillis, 1995; Mercer & Jeffrey, 1995). On the contrary, although Cannabis users have 
impairment while driving, experimental evidence has shown that they may modify their 
driving behavior in order to compensate for impairment. Thus, they are less likely to take
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risks or drive at high speeds, which could possibly result in less fatalities or serious 
injuries (Bates & Blakely, 1999).
Prescription and Illicit Drugs
In addition to alcohol, prescription depressants and painkillers may also affect driving 
(Inaba & Cohen, 2004). Other drugs, which affect a person’s ability to drive include 
cough, cold or allergy medications (Inaba & Cohen, 2004). Combining alcohol with such 
drugs intensifies the effect and makes driving even more dangerous than either drug on 
its own (Inaba & Cohen, 2004). After alcohol, cannabis, benzodiazepines and cocaine are 
the next most commonly detected drugs in drivers involved in motor vehicle accidents 
(Kelly et al., 2004). High levels of benzodiazepines were detected in many European 
countries as well as the United States (Kelly et ah, 2004). Studies have found that 
benzodiazepines, stimulants and opioids equivocally impair driving performance (Kelly 
et ah, 2004). While the most common drugs found in motor vehicle fatalities in Canada 
were eannabinoids, benzodiazepines, codeine, cocaine and barbiturates, in the United 
States, Cannabis, cocaine, PCP and opiates were more common (MacDonald, 2002). 
Woods, Katz, and Winger (1992) found that rates of benzodiazepines in arrested, injured 
and fatally injured drivers ranged from 2% to 9.6% in America.
Of depressants, benzodiazepines are the most commonly studied in relation to 
psyehomotor performance (Ferrara, 1987; Woods et ah, 1992). In Britain, people who 
had prescriptions for sedatives such as benzodiazepines were almost five times more 
likely to be involved in a serious road accident (Skegg, Richards, & Doll, 1979). In a 
study conducted over 17 months in Belgium, urine tests were taken from injured drivers
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at emergency rooms. Of those tests, it was found that those who died as a result of motor 
vehicle accidents were more likely to test positive for benzodiazepines, cannabis, or 
methadone than any other drug (MacDonald, 2002). Laboratory tests have found that 
benzodiazepines may be detrimental to people when trying to operate motor vehicles. 
Inhibition of visual and speed perception, information processing, coordination, reaction 
time, memory and attention are all affected when one is taking such depressants (Kelly et 
al., 2004).
Mortality Rates in the U.S. and Nevada 
In Nevada, unintentional injuries were among the top three leading causes of death in 
ages up to 54 years old while nationally, unintentional injuries were the leading cause of 
death through age 34 (Research Applications, Inc., 2003). The top four mechanisms of 
injury resulting in deaths in Nevada during the year 2001 were suicides, firearm related 
deaths, motor vehicle crashes, and poisonings (including overdoses) (Research 
Applications, Inc., 2003). The leading causes of death resulting from injury among 
Nevada residents in 2001 are as follows: <1 (unintentional suffocation), 1-4 (Homicide 
by other means), 5-9 (Unintentional Motor Vehicle Crashes traffic), 10-14 (Unintentional 
Motor Vehicle Crashes Traffic), 15-24 (Unintentional Motor Vehicle Crashes Traffic, 25- 
34 (Unintentional Motor Vehicle Crashes traffic), 35-44 (Accidental Poisoning or 
Overdose), 45-54 (Accidental Poisoning or overdose), 55-64 (Unintentional Motor 
Vehicle Crashes Traffic) and 65+ (Unintentional Motor Vehicle Crashes Traffic) 
(Research Applications, Inc., 2003).
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During 2001, homicide in Nevada was the second most frequent cause of death for 
people ages 15-24 and fourth for those between the ages of 25-34 (Research 
Applications, Inc., 2003). Although homicides are most common among teenagers and 
young adults, they occur in all age categories (Research Applications, Inc., 2003). 
Furthermore, males are more likely to be victims and perpetrators in homicides, and 
between the years of 1976 and 1997, a study conducted by Fox (Bureau of Justice 
Statistics, 1998) found that blacks are 7 times more likely than whites to be murdered.
In the United States, approximately 30,000 Americans commit suicide in any given 
year (Wray, 2004). In 2000, Nevada’s residents compromised 19.1 suicides per 100,000. 
These numbers were twice the national average of 10.7 (Wray, 2004). More than 400 
people in Nevada die annually by suicide and of these people, males, residents’ aged 45 
and over. Whites and Native Americans, and those who live in rural counties have higher 
suicide rates (Research Applications, Inc., 2003). Between the years of 1952 and 1996, 
adolescent suicide rates almost tripled in America and from 2000 to 2002, deaths of 219 
Nevada teens (ages 15-19) resulted from homicide, accident or suicide (Wray, 2004). 
Within the same time frame, an alarming 10.8% of middle school students and 8.8% of 
high school students living in Nevada made an attempt at suicide (Wray, 2004).
In 2001, 29,368 people in Nevada were involved in motor vehicle crashes (including 
pedestrians and bicyclists) and a total of 330 deaths resulted from these injuries 
(Research Applications, Inc., 2003). When looking at gender differences in relation to 
motor vehicle crashes, males were more likely than females to have injuries, whether 
they be minor, moderate or fatal (Research Applications, Inc., 2003).
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Prescription Drug Abuse
Over the past 10 years, the abuse of prescription drugs has increased in the United 
States (Compton & Volkow, 2005). Many problems arise when looking at the “epidemic” 
of drug abuse such as addiction, unintentional drug overdose, suicide and crime. 
Oxycontin, oxycodone, benzodiazepines, methadone and psychostimulants are a few of 
the drugs discussed herein. Although used for medicinal purposes, these prescription 
drugs can be extremely harmful to the body if abused illicitly. The public needs to be 
aware of illicit prescription drug abuse in order to help prevent unintentional drug 
overdose and hopefully find treatment programs for people who are at risk of dying from 
a prescription drug overdose. Prescription drug abuse can be defined as; “any intentional 
use of a medication with intoxicating properties outside of a physician’s prescription for a 
bona fide medical condition, excluding accidental misuse” (Compton & Volkow, 2005, p. 
4).
In 2003 approximately 15 million people ages 12 and over living in the United States 
used a psychotherapeutic for non-medicinal purposes (Compton & Volkow, 2005). 
Another study from the National Household Survey on Drug Abuse (NHSDA, 2001) 
reported that Americans between the ages of 18 and 25 were found to have the highest 
prevalence of illicit use of prescription drugs (Office of Applied Studies, 2002). The most 
common sources of illicit prescription drugs contain opioid analgesics, stimulants, 
anxiolytics/sedatives, and sleeping medications. These drugs were easily accessible 
through peers, roommates, boyfriend/girlfriend, family members, and even drug dealers 
(McCabe & Boyd, 2005).
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During the course of any given year, approximately 11 % of the United States adult 
population has been found to have a substance abuse problem (Lester, Andreozzi, & 
Appiah, 2004). Over-the-counter and prescribed medications are the most common drug 
used by pregnant women. Owing to this fact, not only can they be harmful to the mother 
using them, but may harm the unborn fetus as well. The placenta is important in 
protecting the fetus from diffusion of foreign matter into fetal blood; however, it is quite 
permeable to a diverse number of drugs and toxins (Mooney, Boggess, Herbert, & 
Layfield, 1998). Therefore, many prescription drugs may cross the placenta barrier and 
harm the fetus as well. When studying a group of newborns, it was found that half had 
NSAIDs in their first intestinal discharge (Inaba & Cohen, 2004). Drugs such as 
benzodiazepines are incredibly difficult for a fetus to metabolize and can remain in their 
systems for days leading to fetal depression and the possibility of death (Inaba & Cohen, 
2004). This may occur via a phenomenon called ion trapping, which is due to differential 
pH levels or through an increased number of rapidly dividing cells present (Williams, 
James, & Roberts, 2000).
Oxvcontin, Oxveodone and Other Opioids 
One of the fastest growing eoneems for public health and non-medieal use and abuse 
of prescription opioids is OxyContin and its generic competitor. Oxycodone (Bailey, 
Barton, Lezotte, Lowensstein, & Dart, 2006). Approved in 1995 by the FDA, OxyContin 
is an analgesic prescribed to individuals with moderate to severe pain having properties 
similar to that of a narcotic (Cicero, Ineiardi, & Munoz, 2005). Far exceeding reports for 
heroin misuse, the 2003 National Survey on Drug Use and Health (NSDUH) reported that 
4.7 million Americans used prescription pain relievers illicitly within the past month
27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Bailey et al., 2006). When looking at the generic drug, oxycodone, it should be noted 
that it is cheaper to purchase than OxyContin, making the abuse of this drug more 
accessible to the public. Five years after its approval by the FDA, OxyContin abuse 
arose and reports have shown that analgesic abuse can be classified as a national 
epidemic (Cicero, 2005).
In 2002 prescription drugs such as hydroeodone and oxycodone were found to be the 
most prevalent opioids resulting in trips to the emergency room, especially when used 
concomitantly with other drugs (McCabe et ah, 2005). Showing an upward trend in the 
use of medications illicitly, it has been found that over two million persons aged 12 and 
older in the United States reported using opioid analgesics in 2000 for their first time 
(Sung, Richter, Vaughan, Johnson, & Thom, 2005). In the mid-1980s it had only been 
recorded that about 400,000 individuals experimented with such drugs for their first time. 
Furthermore, between the years o f 1994 and 2001, the number of emergency room visits 
increased over 300% for oxycodone and over a hundred percent for that of hydroeodone 
(Sung et ah, 2005). This rising trend further confirms how opioid abuse is now becoming 
a drug abuse epidemic.
Methadone and Bupronorphine
The opiate methadone has been designed to be a legal substitute for heroin. Its effects 
are not as intense as the narcotic heroin, yet can be just as addicting (Inaba & Cohen, 
2004). Although methadone maintenance has been used for heroin substance abusers 
since 1994, the abuse of this drug has lead to alarming statistics. Between 1993 and 1994, 
there was a 100% increase in methadone-related deaths in Scotland, whereas there was 
only one reported death attributed to methadone in 1991 (Seymour, Black, Jay, Cooper,
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Weir, & Oliver, 2003). In North Carolina, between the years of 1997 and 2001, the 
number of methadone- related deaths increased from 7 deaths to 58, a 729% increase. In 
2001, a study found that of methadone-related deaths, 21% percent of the decedents were 
prescribed methadone for pain, another 8% was prescribed for an unstated reason and 
19% of the methadone was obtained illegally (Sanford, 2002).
An alternative to methadone, buprenorphine, was approved by the FDA in 2002 
(Jones, 2004). It has been described as a partial agonist for mu receptors in the brain, 
meaning that in some ways it works as a pure opiate agonist such as methadone and 
heroin, but in other ways is non-addictive and has relatively no clinical effects (Resniek, 
Galanter, Pycha, Cohen, Grandion, & Flood, 1992).
Buprenorphine can be distinguished from other opioids such as methadone and heroin 
because it interacts with the mu receptor, uniquely helping people overcome opioid 
addiction (Jones, 2004). Unlike heroin and methadone, once buprenorphine is 
discontinued, withdrawal symptoms are relatively mild (Resniek, 1992). Although more 
expensive than methadone, buprenorphine has a lower rate of illicit use and has also been 
found to be safer with low withdrawal symptoms after discontinuation (Jones, 2004). One 
of buprenorphines beneficial characteristics involves the fact that since it has high affinity 
for the mu receptor, it displaces other opioids (methadone and heroin) from binding to the 
receptors. Thus, if it is given to an individual who has already taken an opioid such as 
heroin, buprenorphine will compete with heroin and help with symptoms of withdrawal 
(Jones, 2004).
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Problems With Prescription Drugs 
Crime
Prescription drugs have been linked to aggression. Studies in rats have shown that 
benzodiazepines may be linked to aggression at moderate dosages. If mixed with alcohol, 
this type of behavior may be increased (Pihl & Peterson, 1995). Benzodiazepines are 
most commonly used with other drugs such as methamphetamines, cocaine and heroin 
(Inaba & Cohen, 2004). The combination of these drugs, especially cocaine, puts users at 
risk for violence. It has been found that pharmacological effects of cocaine induces 
feelings of paranoia, which may lead to eocaine-assoeiated violence (Parker & Auerhahn, 
1998). Thus, prescription drugs such as benzodiazepines can be linked to violence if used 
not only alone, but also in conjunction with illicit drugs such as cocaine.
Suicide
Antidepressants have been found to increase the incidence of suicide. Such 
prescription drugs include Prozac, Zoloft and Paxil. In the United Kingdom it was found 
that people were more likely to commit suicide when first put on antidepressants (Jick, 
Kaye, & Jick, 2004). The FDA has taken action by regulating these drugs with “black 
box” labels warning people of the possibility of suicide. However, it is not certain if the 
suicides were related to the drugs, or that of a mental illness (Prescriptions May Increase 
Risk of Suicide. Retrieved April 8, 2006 from http://www.anxiety-and-depression- 
solutions.eom/artieles/news/suieideriskl 02004.htm). Moreover, in Virginia, 
antidepressants were the most common prescription drugs found in suicide related deaths 
among adolescents and children (Vieweg, Linker, Anum, Turf, Pandurangi, Sood, Fierro, 
& Fernandez, 2005).
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Benzodiazepines have been found to be involved in drug overdoses leading to death 
within all age groups (Carlsten, Waem , Holmgren, & Allebeck, 2003). In younger and 
middle-aged suicide eases, analgesics are most commonly used; however, there has been 
an increase in suicides with benzodiazepines in the elderly population of Sweden over the 
past two decades (Carlsten et ah, 2003).
Unintentional Drug Overdose 
In North Carolina, the number of poisoning-related deaths has increased fastest in the 
nation between the years of 1997 and 2001. More than half of the unintentional related 
overdoses were due to legal or illegal drugs and have increased over a hundred percent 
between these years (Sanford, 2002). In order to prevent unintentional drug-related 
overdoses, counselors, drug rehabilitation centers, and family members of people with 
substance abuse problems need to be aware of the statistics involved with drug overdoses. 
When looking at the deaths caused by accidental drug overdoses, it was found that in 
North Carolina, three quarters of the individuals who died had a history of “one or more 
health problems at the time of their death, including substance abuse (53.8%), alcohol 
abuse or alcoholism (23.8%), chronic pain (20.1%), or mental illness (20.4%)” (Sanford, 
2002, p. 5). Furthermore, “the increase of single-drug deaths resulting from prescription 
narcotics (eg. Oxycodone, methadone) in the five-year period increased from 32 to 96, a 
300% increase” (Sanford, 2002, p. 7).
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Elderly and Preseription Drugs
The elderly represent 13% of the population, but consume 35% of prescription 
medications in the United States (Hanlon, Sehmader, Boult, Artz, & Gross, 2002). The 
most common of these prescriptions include those related to cardiovascular, analgesic 
and central nervous system drugs (Hanlon et. al. 2002). A study conducted in North 
Carolina found that of the following eight different drug classes: calcium channel 
blockers (CCB); angiotensin-converting enzyme (ACE); histaminc2 receptor antagonists; 
nonsteroidal anti-inflammatory drugs; benzodiazepines; antipsychotics and 
antidepressants; benzodiazepines were found to be the most inappropriately prescribed 
drugs (Hanlon et ah, 2002). Of the two different groups of participants studied in North 
Carolina, 21% of one group (n=3,234) and 19.2% of the other group (n=2,508) were 
inappropriately prescribed one or more elements from the eight different drug classes 
(Hanlon et ah, 2002). Another study conducted in Canada found three categories of 
inappropriate prescribing for the elderly:
“(1) the preseription introduces a substantial and clinically significant increase in the risk 
of a serious adverse effect, (2) equally effective or more effective and less risky 
alternative therapy is available for most patients, and (3) the practice is likely to occur 
often enough that a change in practice could decrease morbidity in elderly people” 
(McLeod, Huang, Tamblyn, & Gayton,1997, p. 386).
Benzodiazepines, trieyelic antidepressants and SSRls were common drugs found in 
these three categories, and account for a disproportionate amount of prescribed 
medications in the elderly (McLeod et ah 1997). Unfortunately, because the elderly suffer
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from more illnesses than the young, it is no surprise that they are prescribed a greater 
majority of medications and are at risk for inappropriate use.
Accessibility of Drugs 
More and more people are being prescribed medications for a variety of ailments. 
This places a diverse number of drugs on the shelves and in the medicine cabinets of 
potential substance abusers (NIDA Community Drug Alert, 2005).
Street drugs such as amphetamines and methamphetamines have been a problem 
since the early ‘70’s (Inaba & Cohen, 2004). Not only can substance abusers find cheap 
forms of these drugs on the streets, but the fact that they can be easily manufactured in 
homes or methamphetamine laboratories also explains why these types of drugs may be 
easily accessible (Inaba & Cohen, 2004). Although the Controlled Substance Act of 1970 
helped to regulate the purchase and prescription use of amphetamines, the illegal 
manufacture of these drugs in the form of “crank” became a huge problem. Not only was 
“crank” easily manufactured on the streets, but its purity also made it appealing to drug 
substance abusers (Inaba & Cohen, 2004). Methamphetmaine can be manufactured easily 
with pseudoephedrine. Some common over-the-counter brand names, which are 
popularly used to convert pseudoephedrine to methamphetamine include, Advil Cold and 
Sinus®, Claritin D®, and Sudafed® (Cline, 2005).
Prescribing drugs over the Internet is also a problem. This technology allows access 
to preseription medications, which may explain why an increase in their abuse has 
occurred (Henney & Shuren, 2000). Unfortunately, anyone who has a credit card can 
access the Internet and purchase preseription drugs, without being monitored by a
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physician. Thus, easy access of these drags via the Internet could explain the reason why 
prescription drags are being abused throughout the country.
Accessibility of over-the-counter medications can also be a problem, especially 
owing to the recent rise in methamphetamine laboratories (Cline, 2005). Over-the-counter 
medications are not only easily accessible at grocery and convenience stores, but can be 
abused for the psyehoaetive effects as well (NIDA Research Report Series, 2005).
Large cities such as New York, Dallas, Miami and Philadelphia commonly have high 
accessibility of illicit drags and sales (Lurigio & Davis, 1992). Also, those who live in 
lower socioeconomic class neighborhoods and inner cities are predisposed to problems 
with drags and crime (Lurigio & Davis, 1992). Since the 1980’s violence and hard-drag 
selling has increased among inner cities and drag-traffieking has been found to be higher 
within inner cities rather than in the suburbs (Ensminger, Anthony, & McCord, 1997; 
Johnson, Williams, Dei, & Sanabria, 1990). Between 1990 and 2000, Las Vegas was the 
largest of the fast-growing cities (O’Hare, 2001). Not only is Las Vegas at risk for high 
drag trade on the streets, but is also a potential reservoir for illicit drag use and crime. 
Based on review of the literature, several research questions became apparent. 
Question 1 : What are the major drugs associated with the four different modes of 
death (suicide, homicide, accident, natural)?
Q2; Is there a relationship between age, gender and ethnicity with the types of drags 
detected in the body after death?
Q3: Is there an association between prescription drags and mortality?
Several testable hypotheses were generated from these research questions and are 
presented in the following chapter.
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CHAPTERS
OBJECTIVES, QUESTIONS, HYPOTHESES 
This chapter presents objectives, questions and hypotheses. Objectives will be presented 
first, followed with three questions and corresponding hypotheses.
Objectives
The following objectives were developed for this thesis.
• This study will identify the most common drugs found in 
postmortem toxicology screenings in Clark County, Nevada for 2005
• This study will evaluate the drugs found in toxicology screenings of decedents related 
to age, gender and ethnicity
• This study will evaluate drugs found in toxicology screening related to accidents, 
homicides, suicides and natural related deaths
• This study will examine pharmacotherapeutic interventions and determine what 
prescription drugs are associated with mortalities
Questions and Hypotheses;
From the above objectives the following questions and hypotheses were developed for 
this thesis.
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Question 1
What are the major drugs associated with the four different modes of death (suicide, 
homicide, accident, natural)?
Hypothesis 1(a): Those drugs that are easily accessible (e.g. Prescription drugs, over-the- 
counter medications) will be most common in postmortem toxicology screenings 
Method: A contingency table will be used to examine the distribution of drugs 
Hypothesis 1(b): Inexpensive drugs (e.g. preseription, over-the-counter medications) will 
be highly prevalent in postmortem toxicology screenings
Method: A contingency table will be used to examine the distribution of drugs 
Hypothesis 1(e): Alcohol will be most prevalent in motor vehicle fatalities
Method: A contingency table will be used to examine the distribution of drugs
Question 2
Is there a relationship between age, gender and ethnicity with the types of drugs 
detected in the body after death?
Hypothesis 2(a): Teenagers will be more likely to have drugs such as cannabis and 
alcohol
Method: A contingency table will be used to examine the distribution of drugs 
Hypothesis 2(b): Males will be more likely to have a higher prevalence of drugs in their 
bodies than females
Method: A contingency table will be used to examine the distribution of drugs 
Hypothesis 2(c): There will be a difference in drug use among ethnicities
Method: A contingency table will be used to examine the distribution of drugs
36
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Hypothesis 2(d): Accidents and homicides will be one of the leading causes of deaths for 
children/infants
Method: A contingency table will be used to analyze causes of death in 
children/infants
Question 3
Is there an association between prescription drugs and mortality?
Hypothesis 3(a): Owing to easy accessibility in prescription drugs, there will be higher 
rates of prescription drug related mortalities
Method: Analyses of frequencies will be used to determine the distribution of drugs 
Hypothesis 3(b): Depressants (benzodiazepines, barbiturates) will be the most commonly 
found drugs in the elderly (aged 65+)
Method: Analyses of frequencies will be used to determine the distribution of drugs
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CHAPTER 4 
METHODOLOGY
This chapter discusses the methodology associated with postmortem toxicology 
findings. Furthermore, the collection, categorization and statistical analyses of data will 
be presented.
Data
The data analyzed were taken from toxicology reports from the Quest Diagnostics 
Laboratory in Las Vegas, Nevada. Gas-Chromatography-Mass-Spectrometry was used to 
determine what toxieologieal substances were found in postmortem specimens. 
Specimens analyzed were blood, urine, liver, brain tissue, decomposition fluid and 
vitreous fluid. An Institutional Review Board (IRB) exemption (0606-1993) was filed 
with the UNLV Office for the Protection of Human Subjects and approved in order to 
conduct research with the data obtained.
All data in the database represented counts; therefore all data were analyzed using 
contingency tables. A ehi-square or equivalent statistic was calculated for each 
contingency table.
After analyzing all data, some of the results were broken down into two different 
tables. One of the tables examined the results out of the total N (2426) while the other 
table examined the data within age, drug, gender or ethnicity categories. This was done
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because different patterns were seen when examining the data within the total N as 
opposed to a particular category.
Age Categories
The following age categories, taken from the National Survey on Drug Use and 
Health, will be examined in order to find associations among age, fatalities and the types 
of drugs found postmortem. The following age categories were used: gestation, 
newborn/infant (<1 year), toddlers (1-4), children (5-11), middle and high school (12-17), 
college age (18-25), young adulthood (26-34), career and family (35-49), middle age (50- 
64) and retired (65+).
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CHAPTER 5 
RESULTS
The following results will address each question and relevant hypotheses addressed in 
this thesis. Appropriate chi-square distributions will be listed, as well as tables presenting 
overall results for all statistical analyses conducted in this thesis.
Males, Caucasians and those 65 years and above represented the greatest number of 
decedents. Accident-related deaths were highest of all modes of death (41.2%) with 
natural related deaths (37.6%) consisting of the next largest number of deaths found. 
Suicides consisted of 13.4% of all deaths, while homicides were at 7.8% (Tables 2 & 3).
 ̂Table 2 Prevalence of mode of death separated by gender (within total N).
MODE Female
%(n)
Male
% (n)
Natural 12.3 (298) 25.3 (613)
Accident 13.9 (336) 27.4 (663)
Suicide 3.0 (72) 10.4 (252)
Homicide 1.6 (39) 6.2(151)
‘ A Chi-square analysis was used to determine the prevalence of mode of death separated 
by gender within 2,426 decedents from the Clark County Coroner’s Office in 2005.
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Table 3 Prevalence o f gender, ethnicity, mode o f death and age.
Variable Category *Pereent Frequency
Male 69.2 1679
Gender Female 30.7 745
Caucasian 75.1 1823
African American 11.0 267
Ethnicity Hispanic 11.1 269
Asian 2.8 67
Natural 37.6 913
Accident 41.2 999
Mode of Death Suicide 13.4 324
Homicide 7.8 190
Gestation .5 12
<1 (Newborn/Infant) 1.5 36
1-4 (Toddler) 1.2 30
5-11 (Childhood) .5 11
12-17 (Middle and High 
school)
1.7 42
Age 18-24 (College) 9.2 224
25-34 (Young Adulthood) 9.6 234
35-49 (Career and Family) 23.8 684
50-64 (Middle Age) 23.5 571
65+ (Retired) 28.2 684
*Total percent may not sum to 100% owing to non-reporting within certain variables
A more interesting result is found when examining death within the gender specific 
death category. When examining the data this way, females represented a greater 
majority of natural (40.0%) and accident-related deaths (45.1%) than males (Table 4).
Table 4 Prevalence of mode of death found within gender specific categories.
MODE Female n=745 
% (n)
Male n=1679 
%(n)
Natural 40.0 (298) 36.5 (613)
Accident 45.1 (336) 39.5 (663)
Suicide 9.7 (72) 15.0(252)
Homicide 5.2 (39) 9.0(151)
 ̂Prevalence of gender, ethnicity, mode of death and age categories found in 2,426 
decedents from the Clark County Coroner’s Office in 2005.
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Question 1 addressed the major drugs found in four different modes of death (suicide, 
homicide, accident, natural). Of all decedents, ethanol was the most common substance 
found in natural-related deaths (7.1%) followed by opioids and morphine derivatives 
(3.4%) and depressants (2.0%). In accident-related deaths, opioids and morphine 
derivatives were highest (14.2%) followed by ethanol (9.7% ) and stimulants (9.4%). 
Ethanol was found to be the most prevalent substance found in those who committed 
suicide (4.3%) followed by opioids and morphine derivatives (2.8%) and depressants 
(2.7%). In homicide-related deaths, ethanol (2.3%), stimulants (2.3%) and eannabinoids 
(1.7%) were the most prevalent substances found. More prescription medications, 
including antidepressants, depressants and opioid and morphine derivatives were found 
than expected by chance (x^=71.458, p<.05) in accident and suicide-related deaths. 
However, less over-the-counter medications were found than expected by chance in 
accident, suicide, and homicide-related deaths (x^=12.366, p=.015). Furthermore, the 
prevalence of alcohol in relation to suicides and homicides was found to be dependent 
(X'=29.095, p<.001) (Table 5).
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Drug Categories/Mode of 
Death
Natural
%(n)
Accident
%(n)
Suicide
%(n)
Homicide
%(n)
Anabolic Steroids 0(0) 0(0 ) 0(1) 0(1)
Analgesics 1.7(42) 2.3(55) 1.4 (33) 0.1 (2)
Antidepressants 0.6 (14) 1.8(43) 1.0(24) 0.0(1)
Cannabinoids 1.2(28) 3.8(92) 1.2(28) 1.7(41)
Depressants 2.0 (49) 7.0(170) 2.7(66) 0.5 (12)
Dissociative Anesthetics 0(0) 0(1) 0(0) 0.1 (2)
Ethanol 7.1 (173) 9.7 (235) 4.3 (104) 2.3 (57)
Inhalants 00% 0(1) 0(0) 0(0)
Opioids and Morphine 
Derivatives
3.4(82) 14.2 (343) 2.8 (67) 0.5 (12)
Other Compounds 1.1 (29) 1.5(36) 0.5(11) 0(1)
Over-the-Counter
Medications
1.0(24) 0.8 (20) 0.7 (18) 0.2 (4)
Prescription Medications 1.7 (41) 5.2 (125) 1.3(32) 0.4 (9)
Stimulants 1.5 (36) 9.4 (227) 1.9(47) 2.3 (56)
 ̂Data from 2,426 decedents were statistically analyzed using chi-square analysis. The 
prevalence of drugs present in decedents was determined within each mode of death.
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A more striking pattern is found when examining drugs found within the four modes 
o f death. Of all natural deaths, ethanol (18.7%) was the most common substance found in 
decedents followed by opioids and morphine derivatives (9.0%) and depressants (5.4%) 
Of all accident-related deaths, opioids and morphine derivatives were most prevalent 
(24.4%) followed by ethanol (23.7%) and stimulants (22.8%). Of all those who died of 
suicides, ethanol (32.0%), opioids and morphine derivatives (21.0%) and depressants 
(20.4%) were the most common substances found. Of all homicide-related deaths, 
ethanol (29.3%) stimulants (28.8%) and cannabinoids (21.2%) were most prevalent.
Table 6 Prevalence of mode of death separated by drug categories (within mode of 
death
Drug Natural Accident Suicide Homicide
Categories/Mode of n=925 n=1008 n=328 n=198
death
Anabolie Steroids 0(0) CX3(1) CX5(1)
Analgesics 4.5 (42) 5.6(56) 10.4 (34) 1.0(2)
Antidepressants 1.5(14) /L2(42) 7.3 (24) (X5(l)
Cannabinoids 3.0(28) Sfl(92) 8.5 (28) 21.2(42)
Depressants 5.4 (50) 17.2(173) 20.4 (67) 6.6(13)
Dissociative 0(0) 0.1 (1) (k0(0) 1.0(2)
Anesthetics
Ethanol 18.7 (29) 23.7 (36) 32.0 (11) :29.3 (1)
Inhalants 0(0) 0.1 (1) 00% 0(0)
Opioids and Morphine 9.0(83) 34.4 (347) 21.0(69) 6.6(13)
Derivatives
Other Compounds 3.1(173) 3.6 (239) 3.4(105) 0.5 (58)
Over-the-Counter 2.6 (24) 2.0(20) 5.8 (19) 2:0(4)
Medieations
Prescription 4.5 (42) 12.4 (125) 9.8 (32) 5.1 (10)
Medications
Stimulants 4.0 (37) 22.8(230) 14.3 (47) 28.8 (57)
Drugs were statistically analyzed using chi- square analysis. Each mode of death was 
examined and the prevalence of drugs present in decedents was determined.
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Of all decedents who died of motor vehicle accidents (MVA), 25.5% had ethanol in 
their toxicology results, 10.8% had cannabinoids and 6.9% had opioid and morphine 
derivatives. More alcohol was found than expected by chance in all decedents who died 
of motor-vehicle fatalities (x^=29.095, p<.001; Table 7). When examining all suicide- 
related deaths, 2.1% of the decedents were found to have both ethanol and 
opioid/morphine derivatives in their toxicology screening.
Table 7 Prevalence of drugs present in decedents who died of motor vehicle fatalities in 
Clark County Nevada, 2005.
Drug Categories/Motor Vehicle 
Accidents
Motor Vehicle Accidents n=259 
% (n)
Anabolic Steroids 0(0)
Analgesics 2.7 (7)
Antidepressants 0.4 (1)
Cannabinoids 10.8 (28)
Depressants 5.0(13)
Dissociative Anesthetics 0(0)
Ethanol 25.5 (66)
Inhalants 0(0)
Opioids and Morphine Derivatives 6.9 (18)
Other Compounds 3.9(10)
Over-the-Counter Medications E5t%
Prescription Medications 4.6 (12)
Stimulants 10.4(27)
Question 2 addressed the relationship among age, gender and race with the types of 
drugs detected in the body after death. After examining age and the type of substance 
found in decedents, there were more cannabinoids than expected by chance within those
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between the ages of 12 and 17 (x^=225.483, p<.001). This finding was also consistent 
with those who were between 18 and 25 years of age. A greater number of college-age 
decedents (18-25) were also found to have more alcohol in their toxicology screenings 
than expected by chance (x^=l08.505, p<.001).
Of all decedents, stimulants were most commonly found within the gestation age 
category (0.2%) while depressants and analgesics were most commonly found in those 
less than one year of age. Ethanol (3.0%) was the most prevalent substance found in 
college age decedents followed by cannabinoids (2.5%) and stimulants (2.0%). Ethanol 
(3.1%), opioids and morphine derivatives (2.9%) and stimulants (2.7%) were most 
common in young adulthood. Opioids and morphine derivatives (7.5%) represented the 
majority of substances found in those within the career and family age group followed by 
ethanol (6.7%) and stimulants (6.6%). Furthermore, ethanol was the most common 
substance found in middle age decedents (6.4%) and those who were 65 years of age and 
older (3.7%) (Table 8).
Of all antidepressants, prescription medications, depressants, analgesics, 
cannabinoids, opioid and morphine derivatives, stimulants, and ethanol, decedents within 
the career and family age group (aged 35-49) represented the highest number of these 
substances. Of all dissociative anesthetics (n=3), those in young adulthood represented 
the highest majority of decedents. When examining all over-the-counter medications 
(n=66) found in decedents, those who were between the ages of 50 and 64 had the highest 
prevalence of these substances (34.8%) (Table 9).
Furthermore, it is important to examine drug prevalence within specific age 
categories. Of all decedents who were between 12 and 17 years of age and those within
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college years (18-25), ethanol and cannabinoids represented the majority of substanees. 
Ethanol and opioids and morphine derivatives were most common among all those who 
were 26 years or older. Ethanol represented the majority of substances found within the 
elderly population (65+) followed by opioid and morphine derivatives and depressants. 
Although depressants were not the most common substances detected, they did represent 
5.8% of the drugs found within those who were of 65 years of age and older. (Table 10).
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^Table 8 Prevalence of drug categories separated by age (within total N)
oo
Drug
Categories/Age
Gestation
% ( n )
<1 yr 
(newbom 
or infant)
% ( n )
1-4
(Toddler)
% ( n )
5-11
(Childhood)
% ( n )
12-17 
(Middle 
and high 
school) 
% ( n )
18-25
(College)
% ( n )
2 6 3 4
(Young
Adulthood)
% ( n )
35-49
(Career
and
Family)
% ( n )
50-60
(Middle
Age)
% ( n )
65+
(Retired)
% ( n )
Anabolic
Steroids
Analgesics
Anti­
depressants
Cannabinoids
Depressants
Dissociative
Anesthetics
Ethanol
Inhalants
Opioids and
Morphine
Derivatives
Other Compounds
Over-the-
Counter
Medications
Prescription
Medications
Stimulants
0(0) 0 ^ 0 o m ) 0 ^ 0 C)(0) 0(% 0 4 ( 0 0(0) OW) o # 0
0(0) 0 3 ( 4 ) 04(2) o # 0 0.1(2) C 2 0 4 0.7(17) 2.0 (48) E4CD) 0.9(21)
0(0) 0 ^ 0 0 ^ 0 0 ^ 0 0 ( 0 0 4  D) 0 3 ( 5 ) 1.4(35) 1.1 (27) 0.4 (10)
0(0) O#0 OQ) 0(0 ) 0.3(8) 2.5 (60) 1.6(38) 2.5 (60) 0.9 (21) 0 4 ( 0
0(0) 0 3 ( 4 ) OQ) 0 4  CO 0 4  (2) 0.8 (20) 1.8 (43) 4.4 (106) 3.3 (80) 1.7(40)
0(0) om ) 0 ^ 0 0 ^ 0 0 ^ 0 0 ( 0 0.1(2) 0(0) 0 (0 ) 0 (0)
0 (1 ) 0(1 ) 0 ^ 0 0 ( 0 0.4 (10) 3.0 (73) 3.1 (75) 6.7 (162) 6.4 (155) 3.7 (89)
0(0) 0 ^ 0 0(0) 0 ^ 0 0 ^ 0 0 ( 0 0 (0 ) o # 9 0 ^ ) 0 (0 )
0 (1) 0.1(2) 0(1) 0 ^ 0 0 4  (3) 1.5(37) 2.9 (71) 7.5 (181) 5.7(138) 2.9 (70)
0.0(1) 0.0(1) 0 ^ 0 0(0) 0.0(1) C 3 # 0 0.3(8) 1.2(28) 0.7 (18) 0 3  (12)
0 ^ 0 0.1(2) 0(0) 0 ^ 0 0 ( 0 C 2 # ) 0 3 ( 6 ) 0.6 (15) &9CM) 0.5(13)
o m ) 0.1(3) OTHQ 0.0(1) 0.1(3) 0.6 (15) 1.0(25) 3.5(85) 2.0 (48) 1.1 (27)
0.2 (5) 0.1(3) o (H 0(0) 0 (0 ) 2.0 (48) 2.7 (66) 64) (161) 2 8 # # ) 0.5 (13)
 ̂Data from 2426 decedents were taken from the Clark County Coroner’ s Office in 2005. The prevalence of drugs found in decedents 
was examined using chi-square analysis.
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Table 9 Prevalence of drug categories separated by age (within drug categories)
Drug
Categories/Age
Gestation
%(n)
<1 yr 
(newborn 
or infant) 
%(n)
1-4
(Toddler)
%(n)
5-11
(Childhood)
%(n)
12-17 
(Middle 
and High 
school) 
% ( 0
1&35
(College)
%(n)
26-34
(Young
Adulthood)
%(n)
35-49
(Career
and
Family)
% ( 0
50-60
(Middle
Age)
%(n)
65+
(Retired)
%(n)
Anabolic 
Steroids n=2
0(0) o # o 0 # ) 0 # 9 0(0) 0 ( 0 100.0 (2) 0 0 ) 0 0 ) 0 0 )
Analgesics n=132 0(0) 3 0(4) 1.5(2) o # 9 1.5(2) 3.8(5) 12.9(17) 36.4 (48) 25.0 (33) 15.9 (21)
Anti-depressants
n=81
Cannabinoids
n=189
0(0) OQ) o # o 0 0 ) 1.2(1) 3.7(3) 6.2(5) 43.2 (35) 33.3 (27) 12.3 (10)
0 (Q o # o OQ) 0 0 ) 4.2(8) 31.7 (60) 20.1 (38) 31.7(60) 11.1 (21) 1 4 ( 2 )
Depressants n=297 0(0) 1.3(4) OQ) 0.7(2) 0:7(2) 6.7 (20) 14.5 (43) 35.7 (106) 26.9 (80) 13.5 (40)
Dissociative 
Anesthetics n=3
0(0) o # o OQ) 0 0 ) 0(0) 333  (1) 6C7(2) 0 0 ) 0 ( 0 0 0 )
Ethanol n=569 0.2(1) 0.2(1) o # o 0.2(1) 1.8 (10) 12.9(73) 13.2(75) 2&6(1&0 27.3 (155) 15.7 (89)
Inhalants n=l 0 (0) o # 9 o m ) 0 0 ) 0 (0) 100.0(1) 0 0 ) 0 0 ) 0 0 ) 0 0 )
Opioids and 
Morphine 
Derivatives n=504
0.2(1) 0.4(2) 0.2(1) 0 0 ) 0.6(3) 7.3 (37) 114.1 (71) 35.9 (181) 27.4 (138) 13.9 (70)
Other Compounds 
n=77 
Over the 
Counters
Medications n=66
1.3(1) 13 (1 ) o # 0 OQ) 1.3(1) 10.4(8) 10.4 (8) 36.4 (28) 23.4(18) 15.6 (12)
0 (0 ) 3.0(2) OQ) 0 0 ) 1.5(1) 9 4 ( 0 9 4 ( 0 22.7(15) 34.8 (23) 19.7(13)
Prescription 
Medications n=207
0(0) 1.4(3) 0.0(0) 0.5(1) 1.4(3) 7.2(15) 12.1 (25) 41.1 (87) 23.2 (48) 13.0 (27)
Stimulants n=366 1.4(5) 0.8(3) 0(1) 0 0 ) 0(0) 13.2 (48) 18.1 (66) 44.1 (161) 18.6 (68) 3.6 (13)
Chi-square analysis was conducted on data from the Clark County Coroner’s Office, 2005. Of all drug categories, the prevalence of 
drugs was found separated by age.
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^Table 10 Prevalence of drug categories separated by age (within age categories)
O
Drug
Categories/
Age
Gestation
n=12
%(n)
<1 yr
(newborn 
or infant) 
n=36 
% (n)
1-4
(Toddler)
n=30
%(n)
5-11
(Childhood)
n = ll
%(n)
12-17 
(Middle and 
High school) 
n=42 
%(n)
18-25
(College)
n=224
%(n)
26-34
(Young
Adulthood)
n=234
% (n)
35-49
(Career and 
Family) 
n=578 
%(n)
50-64
(Middle 
Age) n=571 
%(n)
65+
(Retired)
n-684
%(n)
Anabolic
Steroids
0 0 ) 0 (0 ) 0(0) 0 (0 ) 0 (0 ) 0 (0 ) 0.9 (2) 0 (0 ) 0 (0 ) 0 (0 )
Analgesics 0 0 ) 11.1(4) 6.7(2) 0(0 ) 4 .8(2) 2 .2(5) 7.3 (17) 8.3 (48) 5 3 (3 3 ) 3.1(21)
Anti­
depressants
0 0 ) 0 ( 0 0 ( 0 0 (0 ) 2 .4(1) 1.3(3) 2.1(5) 6 4  0 5 ) 4.7 (27) 1.5 (10)
Cannabinoids 0 0 ) 0 ( 0 0 ( 0 0 (0 ) 19.0 (8) 26.8 (60) 16.2(38) 10.4 (60) 3.7(21) C3 0 )
Depressants 0 0 ) 11.1(4) 0 (0 ) 1 8 3 (2 ) 4 .8(2) 8.9 (20) 18/1(43) 183 (106) 14.0 (80) ^8 0 0
Dissociative
Anesthetics
0 0 ) 0 ( 0 0 ( 0 0 (0 ) 0 (0 ) 0 .4(1) 0.9(2) 0 (0 ) 0 ( 0 0 ( 0
Ethanol 8.3 (1) 2 .8(1) 0 ( 0 9.1(1) 23.8 (10) 32.6 (73) 32.1 (75) 28.0(162) 274 0 5 5 ) 13.0 (89)
Inhalants 0 0 ) 0 (0 ) 0(0) 0 (0 ) 0 (0 ) 0 .4(1) 0 0 ) 0 0 ) 0 0 ) 0 ( 0
Opioids and
Moiphine
Derivatives
8 3 (1 ) 5 .6 ( 0 3.3(1) 0 (0 ) 7 .1(3) 16.5 (37) 30.3 (71) 3 1 4 (1 8 1 ) 24.2 (138) 10.2 (70)
Other
Compounds
83  (1) 2 .8(1) 0(0 ) 0 (0 ) 2 .4(1) 3 .6(8) 3 4 ( 0 4.8 (28) 3.2 (18) 1.8(12)
Over the 
Counter 
Medications
0 0 ) ^ 6 0 ) 0(0) 0 (0 ) 2 .4(1) 2 3 ( 0 2 5 (6 ) 2.6(15) 4.0 (23) 1.9(13)
Prescription
Medications
0 0 ) &3 0 ) 0(0) 9.1 (1) 7 .1(3) 6.7 (15) 10.7 (25) 14.7 (85) 8.4 (48) 2 9 (2 7 )
Stimulants 41.7(5) 8 .3(3) 3.3(1) 0 (0 ) 0 (0 ) 21.4 (48) 28.2 (66) 27.9(161) 11.9 (68) E9(13)
’ Data from the Clark County Coroner’s office in 2005 were analyzed statistically using chi-square analysis. Of all decedents who 
were categorized into different age categories, the prevalence of drugs present was reported.
Of all decedents, opioids and morphine derivatives were the most commonly found 
substances found in females (7.8%) followed by depressants (4.9%) and ethanol (4.0%). 
Males were most likely to have ethanol in their toxicology screenings (19.5%) followed 
by opioids and morphine derivatives (13.0%) and stimulants (11.6%). More prescription 
medications were found than expected by chance in females, whereas less were found in 
males (%^=18.600, p<.001; Table 11).
^Table 11 Prevalence of drug categories separated by gender (within total N)
Drugs/Gender Female
%(n)
Male
%(n)
Anabolic Steroids 0 (0 ) 0 0 (2 )
Analgesics 2.1(52) 3.3 (80)
Antidepressants 16(38 ) 1.8(43)
Cannabinoids 1.2(30) (x6(159)
Depressants 4L9(118) 7.4(179)
Dissoeiative Anesthetics 0(0) 0.1 (3)
Ethanol 4.0 (96) 19.5(473)
Inhalants 0(0) 0(1)
Opioids and Morphine 
Derivatives
7.8 (190) 13.0(313)
Other Compounds 0.9 (21) 2.3 (56)
Over-the-Counter
Medications
0.9 (23) 1.8(43)
Prescription Medications 3.8(91) 4.8(116)
Stimulants 3.5(85) 11.6(281)
* Data from 2426 deeedents were taken from the Clark County Coroner’s office in 2005. 
Chi-square analysis was used to statistically analyze the prevalence of drugs present in 
decedents who were eategorized by gender.
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Of all drug categories, males outnumbered females in the prevalence of substances 
found in toxicology screenings (Table 12).
^Table 12 Prevalence of drug eategories separated by gender (within drug categories)
Drugs/Gender Female
%(n)
Male
%(n)
Anabolic 
Steroids (n=2)
0(0) 100.0(2)
Analgesics (n=132) 39.4 (52) 60.6 (80)
Antidepressants (n=81) 46.9 (38) 53.1 (43)
Cannabinoids (n=189) 15.9(30) 84.1 (159)
Depressants (n=297) 39.7(118) (%l.3(179)
Dissociative 
Anesthetics (n=3)
0(0) 100.0 (3)
Ethanol (n=569) 16.9 (96) 83.1 (473)
Inhalants (n=l) 0(0) 100.0(1)
Opioids and 
Morphine
Derivatives (n=504)
37.7(190) 620(314)
Other Compounds (n=77) 27.3 (21) 72.7 (56)
Over-the-Counter 
Medications (n=66)
3Afr(2% 65.2 (43)
Prescription 
Medications (n=207)
44.0 (91) 56.0(116)
Stimulants (n=366) 23.2 (85) 76.8(281)
 ̂Data taken from the Clark County Coroner’s Office from 2005 were analyzed 
statistieally. Eaeh drug category was examined and the prevalenee of drugs separated by 
gender was determined using ehi-square analysis.
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Of all female decedents, 25.5% had opioids and morphine derivatives in their 
toxicology screenings followed by depressants (15.8%) and ethanol (12.9%). Of all male 
decedents, ethanol (28.2%) represented the majority of all substances followed by 18.5% 
of opioid and morphine derivatives and 16.7% of stimulants (Table 13).
*°Table 13 Prevalence of drug categories separated by gender (within gender)
Drugs/Gender Female n=707 
% (n)
Male n=1636 
% (n)
Anabolie Steroids 0(0) 0 0 (2 )
Analgesics 7.0 (52) /L8(80)
Antidepressants 5.1 (38) 2.6 (43)
Cannabinoids 4.0 (30) 9.5(159)
Depressants 15.8(118) 10.7 (179)
Dissociative Anesthetics 0(0) 0.2 (3)
Ethanol 12.9 (96) 28.2(473)
Inhalants 0(0) 0.1(1)
Opioids and Morphine 
Derivatives
25.5(190) 18.7(314)
Other Compounds 2.8 (21) 3.3 (56)
Over-the-Counter
Medications
3.1(23) 2.6 (43)
Prescription Medications 12.2 (91) 6.9(116)
Stimulants 11.4 (85) 16.7 (281)
Data taken from the Clark County Coroner’s Office from 2005 were analyzed 
statistically. Each gender category was examined and the prevalence of drugs was 
determined using chi-square analysis.
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Ethanol (2.3%), stimulants (2.1%) and cannabinoids (1.4%) were the most common 
substances found in African Americans. Opioids and morphine derivatives (18.0%) were 
most common in Caucasians followed by ethanol (17.8%) and depressants (10.8%). 
Ethanol .was most commonly found in Hispanics and Asians (Tables 14 & 15).
11Table 14 Prevalence of drug categories separated by ethnicity (within total N)
Drug
Categories/Ethnicity
African
American
%(n)
Caucasian
% (n)
Asian
%(n)
Hispanic
%(n)
Anabolic Steroids 0(0) 0 0 (2 ) 0(0) 0(0)
Analgesics 0.5 (12) 4.2 (102) 0 0 (2 ) 0.7(16)
Anti-depressants Cf3(8) 2.7(66) 0(1) 2(6)
Cannabinoids 1/4(35) 5.5(133) 0(0) 0.9 (21)
Depressants 0.7 (16) 10.8(262) 0.2(4) 0.6(15)
Dissociative
Anesthetics
0.1 (2) 0(0) 0(0) 0(1)
Ethanol 2.3 (57) 17.8(432) 0.4 (9) 2.9 (71)
Inhalants 0(0) 0(0) 0(0) 0(1)
Opioids and Morphine 
Derivatives
1.4 (33) 18 0(436) (X3(8) 1.1(27)
Other Compounds 0.5 (11) 2.5(60) 0(0) (X2(6)
Over the Counter 
Medications
0.3 (8) 2.1 (50) 0(1) 0.3(7)
Prescription
Medications
.7(17) 7.0(171) .2t% .6(15)
Stimulants 2.1 (50) 10.7 (260) 0(1) 2.3(55)
” Data from 2426 decedents were taken from the Clark County Coroner’s Office in 2005. 
A chi-square analysis was used to statistically analyze the prevalence of drugs present in 
decedents who were separated by ethnicity.
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12.Table 15 Prevalence o f drug categories separated by ethnicity (within ethnicity)
Drug Categories/Ethnicity African
American
n=267
%(n)
Caucasian
n=1823
%(n)
Asian n=67 
%(n)
Hispanic
n=269
%(n)
Anabolic Steroids 0(0 ) 0.1 (2) 0 (0 ) 0 (0 )
Analgesics 4.5 (12) 5.6 (102) 3.0 (2) 5.9 (16)
Anti-depressants 3.0 (8) 3.6 (66) 1.5 (1) 2.2 (6)
Cannabinoids 13.1 (35) 7.3 (133) 0 (0) 7.8 (21)
Depressants 6.0(16) 14.4 (262) 6.0 (4) 5.6(15)
Dissociative Anestheties 0.7 (2) 0(0 ) 0(0) 0.4 (1)
Ethanol 21.3 (57) 23.7 (432) 13.4 (9) 26.4 (71)
Inhalants 0(0) 0(0 ) 0 (0 ) 0.4(1)
Opioids and Morphine 
Derivatives
12.4 (33) 23.9 (436) 11.9 (8) 10.0(27)
Other Compounds 4.1 (11) 3.3 (60) 0(0) 2.2 (6)
Over-the-Counter
Medications
3.0 (8) 2.7 (50) 1.5(1) 2.6(7)
Prescription
Medications
6.4 (17) 9.4(171) 6.0 (4) 5.6(15)
Stimulants 18.7 (50) 14.3 (260) 1.5 (1) 20.4 (55)
Data taken from the Clark County Coroner’s Office from 2005 were analyzed 
statistieally. Each ethnicity category was examined and the prevalenee of drugs was 
determined using chi-square analysis.
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As hypothesized, accident and homicide-related deaths were most common among 
toddlers (aged 1-4) and those in childhood years (aged 5-11). Furthermore, more accident 
and homicide related deaths were found than expected by chance (x^=637.484, p<.001). 
Of the 30 children that died between the ages of 1 and 4, over half of them died of 
aceidents, and nearly a quarter of them died as a result of homicide. Approximately 64% 
of those within childhood ages (aged 5-11) died from accidents (45%-motor vehicle 
accidents), while 27.3% died as a result of homicide (Table 16)
Those who were 65 years of age and older represented the majority of all natural- 
related deaths followed by those who were in middle age (aged 50-64) and those within 
eareer and family ages (aged 35-49). Accident-related deaths and suicides were highest 
among those between 35 and 49 years of age, and homicides were highest among those 
between the ages of 18 and 26 (Table 17 & 18). Natural-related deaths were highest 
among those in gestation and who were newborn or infant. Of all deeedents who were 
toddlers (aged 1-4), aecident-related deaths were highest (56.7%) followed by homicides 
(23.3%). Of all decedents who were between 12 and 49 years of age, aceident-related 
deaths were highest while natural-related deaths were most common among all decedents 
who were 50 years of age and older (Tables 16 & 17).
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Age/Mode of Death Natural
%(n)
Accident
%(n)
Suicide
%(n)
Homicide
%(n)
Gestation 0.3 (7) 0.2 (5) 0 (0 ) 0(0 )
<1 (Newborn/infant) 0.9 (29) 0.4 (9) 0(0 ) 0.2 (6)
1-4 (Toddler) 0.2 (6) 0.7 (17) 0(0) 0.3 (7)
5-11 (Childhood) 0(1) 0.3 (7) 0(0 ) 0.1 (3)
12-17 (Middle and 
High school)
0.2 (5) 1.1 (26) 0.4 (9) 0.1 (2)
18-25 (College) 0.7(16) 4.7(113) 1.6 (39) 2.3 (56)
26-34 (Young 
Adulthood)
1.2(29) 4.7(114) 2.1 (50) 1.7(41)
35-49 (Career and 
Family)
6.1 (148) 12.0 (289) 3.7 (90) 2.1 (51)
50-64 (Middle Age) 11.0 (267) 8.6 (209) 3.3 (79) 0.7 (16)
65+ (Retired) 17.1 (413) 8.6 (208) 2.3 (56) 0.3 (7)
Data from 2426 decedents were taken from the Clark County Coroner’s Office in 2005. 
A chi-square analysis was used to statistically analyze the age categories of decedents 
separated by mode of death.
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14,Table 17 Prevalence o f age separated by mode o f death (within age)
Age/Mode of Death Natural
%(n)
Accident
%(n)
Suicide
%(n)
Homicide
%(n)
Gestation n=12 58.3 (7) 41.7(5) 0(0 ) 0(0 )
<1 (Newbom/infant) n=36 58.3 (21) 25.0 (9) 0 (0 ) 16.7(6)
1-4 (Toddler) n=30 20.0(6) 56.7 (17) 0 (0 ) 23.3 (7)
5-11 (Childhood) n=l 1 9.1 (1) 63.6 (7) 0(0) 27.3 (3)
12-17 (Middle and High 
school) n=42
11.9(5) 61.9(26) 21.4 (9) 4.8 (2)
18-25 (College) n=224 7.1 (16) 50.4(113) 17.4 (39) 25.0 (56)
26-34 (Young Adulthood) 
n=234
12.4 (29) 48.7(114) 21.4 (50) 17.5(41)
35-49 (Career and 
Family) n=578
25.6 (148) 50.0 (239) 15.6 (90) 8.8 (51)
50-64 (Middle Age) 
n=571
46.8 (267) 36.6 (209) 13.8 (79) 2.8 (16)
65+ (Retired) n=684 60.4 (413) 30.4 (208) 8.2 (56) 1.0(7)
Data taken from the Clark County Coroner’s Offiee from 2005 were analyzed 
statistically. Each age eategory was examined and the mode of death was analyzed using 
ehi-square analysis.
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Question 3 addressed if  there is an association between prescription drug use and 
mortality. Of all deeedents who died with preseription medications in their toxicology 
screenings, aceident-related deaths were most common, followed by those who died of 
natural-related deaths. Of all decedents who had depressants and antidepressants in their 
toxicology results, accident-related deaths were most common followed by suicides. Of 
those who had opioid and morphine derivatives in their toxicology screenings, 68.1% 
died of accident-related deaths (Table 18).
Of all those who had prescription medications in their toxieology screenings, 
aceident-related deaths (60.4%) were most common, followed by those who died of 
natural causes (19.8). Within the antidepressant drug category accident-related deaths 
were highest (51.9%) followed by suicides (29.6%). Of all those who died with 
cannabinoids, accidents were most prevalent (48.7 %) followed by homicides (21.7%). 
Within all depressants, accidental deaths were highest (57.2%) followed by suicides 
(22.2%). Of all those who died with ethanol in their toxicology screenings, accident- 
related deaths were highest (41.3%). Among all opioids and morphine derivatives, 
accident-related deaths (68.1%).
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15Table 18 Prevalence o f mode o f death separated by drug category (within drug
Drug Categories/Mode of Death Natural
%(n)
Accident
%(n)
Suicide
%(n)
Homicide
%(n)
Anabolic Steroids (n=2) 0(0 ) 0(0) 50.0 (1) 50.0(1)
Analgesics (n=132) 31.8(42) 41.7 (55) 25.0 (33) 1.5 (2)
Antidepressants(n=81 ) 17.3 (14) 51.9(42) 29.6 (24) 1.2(1)
Cannabinoids (n-189) 14.8 (28) 48.7 (92) 14.8 (28) 21.7(41)
Depressants (n=297) 16.5 (49) 57.2 (170) 22.2 (66) 4.0(12)
Dissociative Anesthetics (n=3) 0(0) 33.3(1) 0(0) 66.7 (2)
Ethanol (n=569) 30.4(173) 41.3 (235) 18.3 (104) 10.0 (57)
Inhalants (n=l) 0(0) 100.0(1) 0(0) 0(0)
Opioids and Morphine 
Derivatives (n=504)
16.3 (82) 68.1 (343) 13.3 (67) 2.4 (12)
Other Compounds (n=77) 37.7 (29) 46.8 (36) 14.3(11) 1.3 (1)
Over-the-Counter Medications 
(n=66)
36.4 (24) 30.3 (20) 27.3(18) 6.1 (4)
Prescription Medications 
(n=207)
19.8(41) 60.4(125) 15.5 (32) 4.3 (9)
Stimulants (n=366) 9.8 (36) 62.0 (227) 12.8 (47) 15.3 (56)
Drugs present in decedents were statistieally analyzed using chi- square analysis. Each 
drug category was analyzed and the prevalence of drugs present in decedents was 
determined within each mode of death.
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CHAPTER 6 
DISCUSSION
The major drugs found in postmortem toxicology screenings as well as associations 
among age, gender and ethnicity will be discussed in this section. Potential prevention 
strategies will also be presented as possible solutions in decreasing the occurrence of 
drug-related deaths.
Major Drugs Found in Modes of Death 
Antidepressants, depressants and opioid and morphine derivatives (including heroin 
metabolites) were not included in the prescription medication category analyzed. 
However, all these medications, cumulatively, represented the majority of substances 
found in decedents. Thus, as hypothesized, prescription medications were the most 
common substances found in all decedents who died in Clark County, Nevada in 2005. 
The high number of prescription drugs found in decedents could be a result of over­
prescribing medications from physicians as well as the fact that Internet prescribing is a 
common way of accessing medications for the general population (Henney & Shuren, 
2000). In order to help overcome this problem of prescription medications potentially 
leading to death, future research should be examined this issue in order to change policies 
and laws in regards to doctors who write prescriptions on the Internet, as well as to those 
Internet sites, which allow purchase of prescription drugs. This could help in preventing
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unfortunate instances from occurring, such as prescription drug overdose leading to 
death. In order to prevent unintentional drug-related overdoes, counselors, drug 
rehabilitation centers and family members of people with substance use problems need to 
be aware that prescription drugs are highly prevalent within decedents in Clark County.
After examining the amount of prescription drugs found in decedents, the results 
indicate that we should consider changing policies for physicians in prescribing refills on 
medications, which have the potential for addiction (e.g. hydrocodone, methadone, 
benzodiazepines). Although, the research conducted did not examine whether or not it 
was prescription refills found in decedents, changing policies for how many prescription 
refills are allocated to individuals may help in taking unused medieations off the shelves 
of potential substance users. Another way to prevent prescription medications from being 
abused or sold on the streets would be to have a place for people to return unused 
medications so that they can be properly destroyed.
As the literature suggests, ethanol alone represented the most common substance 
found in all four modes of death (Inaba & Cohen, 2004). However, the data analyzed did 
not take into consideration that decomposing bodies emit a certain percentage of ethanol 
after death. This may bias the results and could be a reason for the high numbers of 
ethanol found in the decedents (O’Neal & Poklis, 1996). Further research as to how much 
ethanol is common in decomposing bodies could be beneficial to future projects related 
to death and postmortem toxicology screenings.
Owing to the high representation of ethanol found among decedents in Clark County, 
programs such as Mothers Against Drunk Driving (MADD), the Nevada National Guard 
Counterdrug Taskforce and Drug Abuse Resistant Education (DARE) need to be aware
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of how many adolescents are dying with ethanol in their bodies. These anti-drug 
programs can potentially help in further educating adolescents about the importance of 
abstinence from drugs and alcohol. Mass Media sueh as advertisements on the radio and 
television, as well as in newspapers and magazines can help in informing the public of 
the alarming statisties related to ethanol and death.
Of all decedents who died of homieide-related deaths, 3.6% of them had both 
benzoyleegonine (a metabolite of cocaine) and ethanol in their toxicology results. The 
combination of these two substances can form cocaethylene. As mentioned in the 
literature review, the presence of coeaethylene can lead to more violent behavior than 
cocaine or ethanol alone (Inaba & Cohen, 2004). This explains why those who had both 
benzoyleegonine and ethanol in their toxieology screenings died as a result of homieide.
Aleohol and Motor Vehiele Fatalities
Consistent with the literature, aleohol was the most prevalent substance found in 
motor vehicle fatalities (Kelly et al., 2004). The next most eommon substances found in 
motor vehicle aceidents were cannabinoids and stimulants. From the data, it is obvious 
that there is not only a high correlation between alcohol and motor vehicle fatalities, but 
there is also a signifieant relationship between alcohol and all modes of death, weather it 
be natural-related causes or those that resulted from homicides. Analyses suggested that 
one out of every four motor vehiele fatalities in Clark County involved alcohol. Law 
makers should therefore eonsider implementing harsher sentences on those who drive 
under the influence. Public health professionals sueh as university educators, counselors 
and physicians need to educate the public, especially those who are most vulnerable (i.e.
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teenagers and college-age individuals) about the deleterious effects alcohol can have on 
one’s life.
Assistance from restaurants and bars can also help in avoidance of drunk drivers 
being on the streets. Phone numbers of taxi services posted on signs within these facilities 
may help those who are intoxicated to take a cab home after a night of drinking. Also, 
volunteer programs designed to drive intoxicated individuals home during peak drinking 
hours could also be beneficial in avoiding fatalities related to ethanol abuse.
Cannabinoids should also be screened for once someone is brought to jail after being 
charged with drunk driving. If such drugs are found upon testing, harsher sentences 
should be given. This could also be implemented against people who are found with other 
drugs such as stimulants, opioids and depressants.
Prevalence of Drugs Found in Age, Gender and Ethnicity
Age
Of all substances, ethanol and eannabinoids were most prevalent in the toxicology 
screening of teenagers. This suggests that anti-drug programs such a DARE and MADD 
need to be not only aware of these statistics, but also need to address people within this 
age group. Individuals within such age categories may be more susceptible to peer- 
pressure and rebellious behavior and therefore attention needs to be focused upon 
teenagers in order to help prevent drug-related fatalities (Gottfredson & Koper, 1996).
Gender
Of all decedents, there was a higher prevalenee of all substances found in males. 
Owing to the fact that males often engage in more rebellious and risky behaviors than
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females, the findings of more drug substances in males, is not surprising (Gottfredson & 
Koper, 1996). However, females were more likely to have prescription medications 
including antidepressants, depressants and opioid and morphine derivatives than males. 
When looking at male decedents, there was a higher prevalenee of ethanol, cannabinoids 
and stimulants than in females. Programs sueh as DARE, MADD and the National Guard 
Counterdrug Taskforce could design classes which focus on preventing males and 
females from becoming substance abusers with drugs they are more susceptible in using. 
The fact that teenagers (aged 12-17) were more likely to have ethanol and cannabinoids 
in their toxicology screenings also suggests that the anti-drug programs may have failed 
in reaching these individuals. This indieates that anti-drug programs should consider 
changing their programs in order to better address adoleseents and substance abuse.
Ethnicitv
Caucasians represented the majority of all decedents. Of all African Americans, 
Asians and Hispanics, ethanol was the most prevalent substance found, while opioids and 
morphine derivative were most commonly found in Caucasians. Statistically, it was 
found that Caucasians were most likely to have substances such as prescription 
medications in their toxicology screenings, while Affiean Amerieans and Hispanies were 
more likely to have substances such as Stimulants and Cannabinoids in their toxicology 
screenings upon death. Thus, as hypothesized, there is a difference in substance abuse 
among ethnicity. Owing to these faets, eourses or programs designed for speeific cultures 
or ethnieities could help educate those who are at risk for drug-related mortality. 
Aecording to the US Census Bureau, nearly a quarter of Nevada’s population in 2005 
consisted of Hispanics (US Census Bureau, 2005). There is a potential language barrier
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among this group of individuals. Coordinating programs that are designed for those who 
are not proficient with the English language could be beneficial in educating not only 
Hispanics, but also other ethnicities and cultures about drug-related mortalities.
Accidents, Homicides and Children 
As hypothesized, accident and homicide-related deaths were the top two leading 
causes of death among toddlers (aged 1-4) and those in childhood years (aged 5-11). It is 
important that parents and law enforcement personnel in Clark County, Nevada are aware 
of the alarming statistics among homicides and accident-related deaths in children.
Parents need to be more cautious when leaving their children unattended for any period 
of time, and lawmakers should consider changing the policies that are enforced against 
parents with any kind of domestic violence history. This can help prevent those who are 
unsuitable for parenthood to either put their children up for adoption or even find help in 
treating their problems. Such alternatives can furthermore prevent children from the risks 
of domestic violence and homieide. Also, implementing higher fines or jail sentences 
against parents who are caught driving recklessly with children could also help in 
preventing accidents among children. Educating and informing day care facilities and 
pre-school workers about the signs of child abuse can also help in preventing homicides 
among young children. Posting phone numbers of domestic violence hotlines such as 
S.A.F.E. House or Safe Nest within child day care facilities for circumstances where 
abuse is suspected may also help in addressing violence against children who are 
vulnerable. Children should also be aware of what abuse is and know how to approach a 
teacher or nanny if  they are being abused by their parents. Lectures in elementary schools
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or pre-schools could educate younger children about the difference between a spanking 
and an unnecessary beating.
Prescription Drugs and Mortality
Prescription drugs (including antidepressants, depressants and opioid and morphine 
derivatives) represented the majority of substances found in all decedents. Whether or not 
these drugs led do the demise o f the decedents, there is obviously a significant 
association among prescription drugs and death. Future research considering policy 
changes could potentially help prevent the abuse of prescription drugs. Education, 
intervention and monitoring of prescription drugs are a few prevention strategies, which 
could be useful in order to control the “epidemic” of prescription drugs. Illicit abuse of 
prescription drugs can lead to precarious events such as crime, homicide, suicide and 
death resulting from accidental overdoses. Informing the public about the statistics when 
it comes to deaths related to prescription drug abuse is important in the prevention of 
serious public health issues. Substituting commonly abused prescription drugs such as 
methadone for buprenorphine also may help in preventing potential problems with 
pharmacotherapeutic drugs (Jones, 2004). Knowing the statistics relating to the abuse of 
prescription drugs will furthermore help encourage public health workers to target high- 
risk groups for prevention and treatment programs.
Ethanol represented the majority of substances found within the elderly (aged 65+) 
followed by opioid and morphine derivatives and depressants. Owing to the fact that 
prescription medications and depressants were among the top three most common 
substances found in decedents, it is obvious that prescription medications are a problem
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among the elderly (aged 65+). Not only can these drugs be misused and abused, but they 
may also lead to death if  not taken as directed. Because the elderly (aged 65+) are closer 
to death and suffering from more ailments than the rest of the population, they may be 
more susceptible to taking a few extra depressants in order to end their lives too soon. 
Physicians need to be aware of the fact that there is a significant statistical correlation 
between elderly (aged 65+) death and prescription medications. Thus, future research 
should look at changing policies related to the possibility of over-prescribing medications 
to the elderly (aged 65+).
Research Limitations
The lack of all concentrations of drug substances prevented pharmacokinetic models 
from being considered. However, alcohol, cocaine and heroin were all quantified and 
could be of use for further studies to examine concentrations of drugs found within 
decedents.
At the time the data were collected, some of the causes of death were pending or 
undetermined. A separate study could be conducted with these data to see if there are 
associations between undetermined deaths and drugs. As mentioned earlier, ethanol is 
common in decomposing bodies. Further research, which would take into consideration 
the exact amounts of ethanol in decomposing bodies released upon death, could also be 
examined in future studies.
Although ethanol and motor vehicle fatalities were examined in this study, it was not 
noted whether or not the decedent was the driver of the car, or a passenger who happened 
to be intoxicated at the time of death. Therefore, future research could examine if  it was
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indeed ethanol which led to the motor vehicle fatality and provide a more accurate study 
relating to motor vehicle deaths and ethanol.
Examining the environment of each decedent could have also been beneficial to this 
study. This can furthermore help in determining the relationship of manners of death and 
the different substances detected in particular demographic areas of Clark County.
Another limitation is that some of the decedents may have been visiting an area in 
Clark County at the time of their death. Although they may have actually lived in another 
state or county, they were examined at the Clark County, Coroner’s office. Furthermore, 
this may bias the results. Therefore looking into the deaths of people who were residents 
of only Clark County may provide a more accurate study when examining associations of 
drugs and death.
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CHAPTER 7 
SUMMARY
This project demonstrated that drugs, whether they be prescription medications, over- 
the counter medications, or illicit substances, may not always be directly associated with 
deaths in Clark County, but that there is a significant relationship among drug use and 
death. Previous research and studies have supported these findings; however, after 
analyzing the data of prescription medications and ethanol in different modes of death, it 
is obvious that there is a problem with drug use leading to death, which needs to be 
addressed.
This study was the first report of drug-related mortalities conducted in Clark County, 
Nevada. It is important to inform the public of the associations between ethnicity, age, 
gender and toxicological findings in different modes of death. Furthermore, examining 
the years prior to 2005 should also be conducted in order to analyze potential trends in 
drug-related mortality.
The public needs to not only be aware of the facts related to drugs and death, but 
action also needs to be taken in order to prevent drug-related mortality. Further research 
should look at changing policies, laws and education practices in order to help decrease 
the prevalence of drugs found in not only postmortem decedents, but also help prevent 
abuse in those who are living. The findings from this research complimented previous 
studies related to drug use, and also showed statistics about death and mortality that have
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not been studied to this date. It is important that research continues to be done in regards 
to mortality and drugs in order to address substance abuse and help prevent unfortunate 
circumstances from occurring within Clark County, Nevada.
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APPENDIX I
ANTIDEPRESSANTS
Common/”street’V 
BRAND NAME
CHEMICAL NAME ‘STRUCTURE
Amitriptyline,
ELAVIL®,
TRYPTANOL®,
ENDEP®,
TRYPTIZOL®
3-(l 0,11 -dihydro-5H-dibenzo[a,d] 
cyclobeptene-5 -ylidene)-N, N- 
dimetbyl-1 -propanamine
c G c )
k ^ . C H 3
1
CH3
b
Bupropion,
WELLBUTRIN®
(±)-1 -(3 -cbloropbenyl)- 
2-[(l, 1 -dimetbyletbyl)amino]- 
1-propanone ÇrVv
Cl
b
’ a-PDR (Physicians Desk Reference); b-www.emolecnles.com
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Citalopram,
CELEXA®
(±)-1 -(3 -dimethylaminopropyl)- 
1 -(4-fluorophenyl)-1,3- 
dihydroisobenzofuran-5- 
carbonitrile, HBr
/
CH2CH2CH2N 
\
-CHa
•HBr
'CHa
Cyclobenzaprine,
FLEXERIL®
3-(5 H  -dibenzo[ a,d ] 
cyclohepten-5 -ylidene)- 
N , N  -dimethyl-1-propanamine 
hydrochloride
HCCH2CH2N(CH3)2'HCI
Desipramine,
NORPRAMIN®,
PERTOFRANE®
Desipramine
Doxepin,
APONAL®
1 l-(3-(Dimethylamino)
propylidene)-6H-
dibenz(b,e)oxepine
H 3 C  C H 3
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Escitalopram,
LEXAPRO®
S-(+)-1 -[3-(dimethyl- 
amino)propyl]-l-( p - 
fluorophenyl)-5- 
phthalancarbonitrile oxalate
NC. /V
y n  r
«cm
T
F
a
Fluoxetine,
PROZAC®
(±)-N-methyl-3-phenyl-3- 
[((alpha),(alpha),(alpha)- 
trifluoro- p - 
tolyl)oxy]propylamine 
hydrochloride
FjC-̂ -̂O-CHCHaCHsNHCHs . HCI
è
a
Imipramine,
ANTIDEPRIN®,
JANMINE®,
TOFRANIL®
Impramine
Hydrochloride
y
1 b
Mirtazapine,
REMERON®
1,2,3,4,10,14b-
hexahydro-2-
methylpyrazino[2,l-a] pyrido
[2,3-c]
henzazepine
CHa
b
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Nortriptyline,
AVENTYL®,
PAMELOR®
3-(10,ll-dihydro-5H-
dibenzo[a,d]
cyclohepten-5-ylidene)- N- 
methyl-1- 
propanamine
0yO
H
b
Paroxetine, 
PAXIL CR®
(3S-trans)-3-((l ,3-Benzodioxol- 
5-yloxy)methyl)- 4-(4- 
fluorophenyl)-piperidine 
hydrochloride
H
F
b
Sertraline,
ZOLOFT®
( 1 S-cis)-4-(3,4-dichlorophenyl)- 
1,2,3,4-tetrahydro-N-methyl-1 - 
naphthalenamine hydrochloride
Cl
b
Trazodone,
DESYREL®
8-[3-[4-(3-
chlorophenyl)piperazin
-l-yl]propyl]-6,8,9-
triazabicyclo[4.3.0]
nona-2,4,9-trien-7-one
D
b
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(R/S)-1 -[2-(dimethylamino)-1 
(4-methoxyphenyl)ethyl] 
cyclohexanol hydrochloride
Venlafaxine,
EFFEXOR®
OH
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APPENDIX II
DEPRESSANTS
Common/”street’7 
BRAND NAME
CHEMICAL NAME 'STRUCTURE
’Alprazolam, 
XANAX XR®
8-chloro-1 -methyI-6- 
phenyl-4 H-s -  
triazolo [4,3-(alpha)j [1,4] 
benzodiazepine
Æ
M l
^Antihistamine Hi-receptor 
Antagonists
X-| Spacer -N
R2
b
* a-PDR (Physicians Desk Reference); b-www.emolecules.com
* Benzodiazepine Class 
 ̂Diphenhydramine
77
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Buspirone,
BUSPAR®
N/A
I ty N
?
b
Butalbital,
AXOCET®,
BUCET®,
BUPAP®
5-(2-methylpropyl)-
5-(2-propenyl)-
2,4,6(1H,3H,5H)-
pyrimidinetrione
H ,c '' 0  „
Clonazepam,
KLONOPIN®
6-(2-chlorophenyl)-9-
nitro-
2,5-diazabicyclo
[5.4.0]
undeca-
5,8,10,12-tetraen-3- 
one
C j K - / '
^Diazepam,
VALIUM®,
SEDUXEN®,
APOZEPAM®
7-chloro-1 -methyl- 
5-phenyl-l,3- 
dihydro-2H- 
1,4-benzodiazepin- 
2-one
H3Ç
x x z f
0
Ethanol Ethyl alcohol
b
Benzodiazepine Class
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Flunitrazepam, 
ROHYPNOL®, 
“forget-me pill,” 
“Mexican Valium,’ 
“R2,” “roofies”
6-(2-fluorophenyl)-2-
methyl-9-nitro-
2,5-diazabicyclo
[5.4.0]
undeca-
5,8,10,12-tetraen- 
3-one
Flurazepam,
DALMANE®
7-chloro-1-[2- 
(diethylamino)ethyl]- 
5-( o -fluorophenyl)-
1.3-dihydro-2 77-
1.4-benzodiazepin- 
2-one di 
hydrochloride
CHgCHgNtCaHsk
o
' 2HCI
Gamma-
Hydroxyhutyrate, 
“GHB”, Fantasy, 
G, Juice, Liquid 
Ecstasy, & 
Gamma-OH, 
XYREM®
4-Hydroxybutanoic
acid
Isopropanol Isopropyl alcohol OH
Lorazepam,
ATIVAN®
9-chloro-6-(2-
chlorophenyl)-4-hydroxy-
2,5-diazabicyclo[5.4.0]
undeca-
5,8,10,12-tetraen-3-
one
Benzodiazepine Class
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Meprobamate,
MILTOWN®
[2 -(carbamoyloxy
methyl)-2 -methyl-
pentyl]
carbamate
CH<
 ̂ 0 - <AO NH,
CH,
Midazolam,
VERSED®,
HYPNOVEL®,
DORMICUM®
8-chloro-6-(2 -
fluorophenyl)-!-
methyl-
4H-Imidazo(l ,5-a) 
(1,4)
benzodiazepine
CH
Oxazepam,
ALEPAM®,
MURELAX®,
SERAX®,
SEREPAX®,
SERESTA®
9-chloro-4-
hydroxy-6 -phenyl-
2,5-diazabicyclo
[5.4.0]
undeca-
5;8,10,12-
tetraen-3-one
Ci
Pentobarbital,
NEMBUTAL®
5-ethyl-5-
(1-methylbutyl)
barbiturate CH3CH2
CH3CH2CH2CH
CH3
M. JONa
Phénobarbital,
LUMINAL®
5-ethyl-5-phenyl-
1,3-diazinane-2,4,6-trione
HN
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Phenytoin,
DILANTIN®
5,5-diphenyl-2,4-
imidazolidinedione _ONa
Primidone,
MYSOLINE®
5-ethyl-5-phenyl-l ,3- 
diazinane-4,6-dione
NH
Temazepam,
RESTORIL®
7-Chloro-1,3-dihydro- 
3 -hydroxy-1 -methyl- 
5-phenyl-
1,4-benzodiazepin-2- 
one
Zolpidem, 
AMBIEN®
N,N,6-trimethyl-2-p- 
tolylimidazo[ 1,2-a] 
pyridine-3-acetamide L- 
(+)-tartrate (2 :1)
N-CH,
CH, coon
H-C-OH
I
HO-C-H
I
COOH
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APPENDIX III
STIMULANTS
Common/”street” 
/BRAND NAME
CHEMICAL NAME "STRUCTURE
Amphetamine, 
BIPHETAMINE® 
“speed,” “bennies,” 
“black beauties,” 
“uppers,” “crosses”
1 -phenylpropan-2-amine
CH:
b
Cocaine,
COCAINE
HYDROCHLORIDE®
“crack,”
“œke”
* Benzoylecgonie
[lR-(exo,exo)]-3-
(Benzoyloxy)-8-
methyl-8-azabicyclo
[3.2.1]octane-2-
carboxylic acid methyl
ester
CH. 0
b
Ephedrine {\R ,25)-2-methylamino- 
1 -phenylpropan- 1 -ol
H
C H 3
b
*”street name” taken from NIDA 
** Cocaine metabolite
a-PDR (Physicians Desk Reference); b-www.emolecules.com
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Methamphetamine, 
DESOXYN®, 
“crystal,” “crank,” 
“ice,” “meth,” 
“speed”
(S)-N-methyl-1 -phenyl- 
propan-2-amine NH CHa
CHa
*Methylenedioxymet 
hamphetamine 
,MDMA, “ecstacy”, 
“E”'
“xfc", “X", “Adam"
1-(benzo[d][l,3]dioxol- 
5-yl)-N-methylpropan-
2-amine
Methylenedioxyamph 
etamine, MDA
3,4-methylene
dioxyamphetamine
Phentermine,
ADIPREX-P®,
OBENIX®,
OBY-TRIM®
(alpha),(alpha)-Dimethyl 
phenethylamine 
hydrochloride
C1@H15N.HCI
ÇH3
CHgC—NH? • HCI 
CH3
* "street names” taken from NIDA
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APPENDIX IV
OPIOIDS AND MORPHINE DERIVATIVES
Common/”street’7 
BRAND NAME
CHEMICAL NAME 'STRUCTURE
Codeine, 
ROBITUSSIN A- 
C®, "cody," 
“Captain Cody”
7,8-didehydro-4,5-epoxy-
3-methoxy-17-
methyImorphinan-6-ol
HO'
a
Fentanyl,
DURAGESIC®
N-Phenyl-N-( I -(2-phenylethyl) 
4-piperidinyl) propanamide
CH, OH, CON—̂  CH, CH;-^~^
Ô
**Hydrocodone,
VICODIN®,
ANEXIA®,
LORCET®,
LORTAB®, “vike,”
“Watson-387”
4,5 a-Epoxy-3 -methoxy-17- 
methylmorphinan-6-one 
tartrate (1:1) hydrate (2:5)
WCH)
CH3O 0  0
a
a-PDR (Physicians Desk Reference); b-www.emolecnles.com 
* Street names taken from NIDA
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Methadone,
DOLOPHINE®
6-(dimethylamino)-4,4- 
diphenyl-3 -heptanone
1
b
Meperidine/Pethidine,
ALGIL®’
DEMEROL®
Ethyl-1 -methyl-4-
phenylpiperidine-4-
carboxylate
N—
0
b
**Morphine, 
ROXANOL®, “M,” 
“Miss Emma,” 
“monkey” 
***Heroin
7,8-didehydro- 
4,5-epoxy-17- 
methylmorphinan-3,6-diol
\ l
a
Nalbuphine,
NUBAIN®
(-)-17-(cyclobutylmethyl)-4, 
5alpha-epoxymorphinan- 
3,6alpha,14-triol hydrochloride
0
HO... i
a
Opiates (morphine, 
codeine)
See morphine/codeine See morphine/codeine
**Oxycodone, 
OXYCONTIN® 
“Oxy," “O.C.,” 
“killer”
4, 5 -epoxy-14-hydroxy-3 - 
methoxy-17-methylmorphinan- 
one
CHjO °  Q
a
''a-PDR (Physician’s Desk Reference); b-www.emolecules.com
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Oxymorphone,
NUMORPHAN®
4.5a-Epoxy-3,14-dihydroxy- 
17-methylmorphinan
CHg
1
N^CH g 
OH 0  °
a
Propoxyphene Ethyl-1 -methyl-4- 
phenylpiperidine-4-carboxylate
0
1
CM, OCCA W
l #W—Ç—C— ' HiO
' Ô
b
Street names taken from NIDA 
*** Narcotic derived from Morphine (6-Monoacetylmorphine-metabolite of heroin)
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APPENDIX V
ANALGESICS
Common/”street”/BRAND
NAME
CHEMICAL NAME 'STRUCTURE
Acetaminophen/Paracetamol, 
TYLENOL®, MIDOL®
N-(4-hydroxyphenyl)
acetamide
H
H c r ^  °  ^
Hydromorphone,
DILAUDID®
4,5-o:-epoxy-3- 
hydroxy 17 -methyl- 
morphinan-6 -one
ÏSICH3 
HO 0 0 a
Ibuprofen, 
ACT3®,ADVIL®, 
BRUFEN®, 
NUPRIN®
2-[4-(2-
methylpropyl)
phenyljpropanoic
acid
a
Ketorlac, TORADOL® (±)- 5 -benzoyl-2,3 - 
dihydro-
lH-pyrrolizine-1- 
carboxylic acid, 
2 -amino-2 - 
(hydroxymethyl)- 
1,3-propanediol
C Jj OH
a
a-PDR (Physician’s Desk Reference); b-www.emolecules.com
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Naproxen (S)-6-methoxy-o!-
methyI-2-
naphthaleneacetic
acid
CH,
•O P
a
Salicylate/Salicylic acid 2 -hydroxybenzoic
acid 0
b
Tramadol, ULTRAM® rac-{\R,2R)-l- 
(dimethylamino 
methyl)-1- 
(3 -methoxyphenyl)- 
cyclohexanol
CH,
b
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX VI
OTC/PRESCRIPTION MEDICATIONS
Common/”street”/ 
BRAND NAME
CHEMICAL NAME 'STRUCTURE
Albuterol,
PROVENTIL®
(alpha) ‘ -[( tert - 
butylamino) methyl]- 
4-
hydroxy- m -xylene- 
(alpha), (alpha)'-diol)
HOCHav^___
HO - < ( 3 /  CHCHgNHC(CH3)3 
OH
a
* Carbamazepine, 
CARBATROL®
5H-dibenz(b,f)
azepine-5-
carboxamide
a
Carisoprodol,
SOMA®
N-isopropyl-2-methyl-
2-propyl-l,3-
propanediol
dicarbamate
CH,
k,ĉ h ,
Chlorphenamine, 
Chlor-T rimeton®
(3RS)-3-(4-
chlorophenyl)-
N,N-dimethyl-
3-(pyridin-2-
yl)propan-I-
amine
ÇH,
H^c'' ' y
V
Clyclobenzaprine 
HCL, FLEXERIL®
3-(5 H  -dibenzo[ a,d'\ 
cyclohepten-5 -ylidene) 
V , A-dimethyl-1- 
propanamine 
hydrochloride
II
HCCH2CH2N(CH3)2 • HCI
a-PDR (Physician’s Desk Reference); b-www.emolecules.com 
* 10-Hydroxycarbazepine-metabolite of carbamazepine
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Colchicine,
COLCHICINE®
N-((7S)-5,6,7,9-
tetrahydro-
1,2,3,10-tetramethoxy- 
oxobenzo(a) 
heptalen-7-yI)- 
acetamide
_  H 0
CM.-0
CK -0
Dextromethorphan, 
DM®, DXM®
D-(+)-3-
methoxy-17 -methyl- 
(9a, 13 0,14a)- 
morphinan
H3CO
CM
H
Dicyclomine,
BENTYL®
[bicyclohexyl]-I- 
carboxylic acid, 
2-(diethylamino) 
ethylester
CHa—CH3
C — O — CHa— CHa— N
CHa— CH3
Digoxin, DIGITEK® 3-((0-2,6-dideoxy-j3- 
D-ribo-hexopyranosyl- 
( 1 -4)-0-2,6-dideoxy- 
|3-D-
ribo-hexopyranosyl-
(l-4)-2,6-
dideoxy-/3-D-
ribo-hexopyranosyl)
oxy)-
12,14-dihydroxy-
,(3|8,5,8,12i8)-
card-20(22)-
enolide
c-H
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Diltiazem,
CARDIZEM®
[2 -(2 -dimethyl
aminoethyl)-
5 -(4-methoxyphenyl)
-3-oxo-6-thia-2-
azabicyclo
[5.4.0]undeca-
7,9,
1 l-trien-4-yl]ethanoate
AX,
Diphenhydramine,
BENADRYL®
2-(Diphenyl 
methoxy) -  
N,N-dimethyl 
ethylamine 
hydrochloride
Diphenoxylate,
Lomotil®
ethyl l-(3-cyano-3,3- 
diphenyl-propyl)- 4- 
phenyl- 
piperidine-4- 
carboxylate
Disulfiram,
ANTABUSE®
Bis(diethylthio 
carbamoyl) disulfide
S S
II II
(CgHglaNC — S — S — CN(CaHs)2
Doxylamine, 
UNISOM® 
NIGHTTIME SLEEP 
AID
N/A
A
N —
/
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Enalapril,
RENITEC®,
VASOTEC®
(S)-1-[N-[I- 
(ethoxycarbonyl)-3 - 
phenylpropyl] -1- 
aIanyl]-l-proIine
H ?
EtOOC. A .
^  cHg y L y  
1 HOOC
b
Fexofenadine,
ALLEGRA®
(±)-4-[l-
hydroxy-4-[4-
(hydroxy
diphenylmethyl) - 1 -
piperidinyl]-
butyl]-(alpha), (alpha)-
dimethyl
benzeneacetic
acid
y = \
w  A i
H0-)—( N Y
a
Gabapentin, 
NEURONTIN® ■
l-(aminomethyl)- 
cyclohexane 
acetic acid
\ ___ A
CHgCOgH
a
Hydroxyzine,
ATARAX®,
UCERAX®,
SERECID®
l-(p-
chlorobenzhydryl) 4- 
[2-(2 hydroxyethoxy)- 
ethyl] piperazine
b
Levetiracetam,
KEPPRA®
(-)-(S)-a-ethyl-2-oxo- 
I-pyrrolidine 
acetamide
^  ^ b
Lithium,
ESKALITH®
Li N/A
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Meprobamate,
MILTOWN®
[2 -(carbamoyl
oxy
methyl)-2 -
methyl-pentyl]
carbamate
k OCONHa
b
Methocarbamol,
ROEWJON®,
ROBAXACET®,
ROBAX
PLATINUM®
[2-hydroxy-3-
(2-[2methoxy
phenoxy)-propyl]
aminoformate
N/A
Olanzapine,
ZYPREXA®,
SYMBYAX®
2-methyl-4-(4-methyl-
I-piperazinyl)-
lOH-thieno
[2,3-b][I,5]
benzodiazepine
o
b
Phendimetrazine,
BONTRIL®
3,4-Dimethyl-2-
phenyl-
morpholine
b
Pheneytoin,
DILANTIN®
5,5-diphenyl-2,4-
imidazolidine
dione
N - /
V  ^  b
Phenmetrazine,
PRELUDIN®
3-methyl-2-
pheny
Imorpholine O
b
Phenylpropanolamine 2-amino-1 -pheny-1 - 
propanol
OH
OT"’
b
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Procainamide,
PRONESTYL®,
PROCAN®,
PROCANBID®
4-amino-N- (2 -diethyl
aminoethyl)
benzamide
structure taken from: 
http://redpoll.pharmacy.ualberta.ca/ 
drugbank/index .html____________
Prochlorperazine,
COMPAZINE®,
BUCCASTEM®,
STEMETIL®
2-chloro-lO- 
[3-(4-methyl-l- 
piperazinyl) 
propyl]-
lOH-phenothiazine (Z) 
-2-butenedioate Cl
structure taken from: 
http://bibleocean.com/OmniDefinition/ 
Prochlorperazine__________________
Promethazine,
PHENERGAN®
N, N,alpha-trimethyl- 
1 OH-phenothiazine- 
10-ethanamine (9CI)
Pseudoephedrine,
SUDAFED®
(l^ ,2^ - 2 -
methylamino-
1-phenylpropan-
l-ol
Quetiapine,
SEROQUEL®
2-[2-(4-dibenzo 
[ b,f] [I,4]thiazepin- 
11 -yl- 1 -piperazinyl) 
ethoxyj-ethanol 
fumarate (2 :1) (salt)
H N +  0— '
' N-Acetylprocainamide-metabolite of Procainamide 
' Norpseudoephedrine-pseudoephedrine metabolite
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Risperidone
"RISPERDAL®
4-[2-[4-(6-fluorobenzo 
[d]isoxazol-3-yl)- 
1 -piperidyl]ethyl]-3- 
methyl-
2 ,6-diazabicyclo
[4.4.0]deca-l,3-dien-5-
one a
Secobarbital,
SECONAL®
5-(I -methylbutyl)-5-
prop-2-enyl-
hexahydro
pyrimidine-
2,4,6-trione
0  b
Sildenafil, VIAGRA® l-[4-ethoxy-3-
(6,7-dihydro-l-
methyl-
7-O X O -3-
propyl-I/7-
pyrazolo[4,3-
rdpyrimidin-5-yl)
phenylsulfonyl]-
4-methyl
piperazine citrate
a
Theophylline
THEO-DUR®,
RESPBID®,
SLO-BID®
I,3-dimethyl-7H-
purine-2 ,6-dione
0
1 >
b
Topiramate,
TOPAMAX®
2,3:4,5-D i-0-
isopropylidene-(beta)-
D-fructopyranose
sulfamate
J — 0  PH2OSO2NH2
9 ....\  y ^ o
H3C CHa
a
9-Hydroxyrisperidone-metabolite of risperidone
95
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Valproic Acid, 
DEPAKENE®
2-propyl 
pentanoic acid
CMg-CHg-CHgv 0
CH3—CH2—C H / OH
a
Verapamil,
ISOPTIN®,
VERELAN®,
CALAN®
2-(3,4-dimethoxy
phenyl)-5-
[2-(3,4-
dimethoxy
phenyl)ethyl-methyl-
amino]
-2-(l-methy
lethyl)
pentanenitrile b
Ziprasidone,
GEODON®
5-[2-[4-(l,2- 
benzisothiazol-3-yl)-1 - 
piperazinyl]
etbyl]
6-chloro-l ,3-dihydro-2 
-  indol-2-one C y,
b
Zolpidem, AMBIEM® N,N,6-trimethyl-
2-(4-methylphenyl)- 
imidazo(l ,2 -a)pyridine
3-acetamide /(-CM,
M,C
b
Zonisamide,
ZONEGRAN®
1,2 -
benzisoxazole-3-
methane
sulfonamide
y N
C H 2 S 0 2 N H 2 ,
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APPENDIX VII
DISOCIATIVE ANESTHETICS
Common/”street”/BRAND
NAME
CHEMICAL NAME STRUCTURE
Ketamine, KETANEST®, 
KETASET®, and 
KETALAR®, “Special K,” 
“K,” “Vitamin K,”
“Cat Valium”
2-(2 -chlorophenyl)-
2-(methylamino)-
cyclohexanone
Phencyclidine, "PCP", “Angel 
Dust”, “sherm”
Phencyclidine
b-www. emolecules. com 
* “street names” taken from NIDA
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APPENDIX VIII
CANNABINOIDS
Common/”street’7BRAND
NAME
CHEMICAL NAME "STRUCTURE
**Cannibis, “hash,” 
“chronic,” MARINOL®
Delta-9-
tetrahydrocannabinol
OH
1 ^
b
b-www. emolecules.com 
* “street names” taken from NIDA
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APPENDIX IX
ANABOLIC STEROIDS
Common/”street”/BRAND
NAME
CHEMICAL NAME STRUCTURE
Boldenone,EQUIPOISE®,
GANABOL®,
EQUIGAN®
1,4-androstadieene-3- 
one,17|8-ol
Nandrolone, DEC A- 
DURABOLIN®
17 (8-Hydroxyestra-4- 
en-3-one
Stanozolol,WINSTROL® 17|8-Hydroxy-17-
methyl-
5a -androstano[3,2-c] 
pyrazole
b-www. emolecules. com
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APPENDIX X
OTHER COMPOUNDS
COMMON/”street’V 
BRAND NAME
CHEMICAL NAME ’STRUCTURE
Acetone |8-ketopropane, 
Dimethyl ketone O
A
h
Arsenic Arsenic As
Bupivacaine,
MARCAIN®,
MARCAINE®,
SENSORCAINE®
l-butyl-A-(2 ,6-
dimethylphenyl)
piperidine-2 -
carboxamide
b
Carbon Monoxide Carbon Monoxide CO
Carboxyhemoglobin N/A COHb
Cyanide hydrogen cyanide, 
cyanogen chloride, 
sodium cyanide, 
potassium cyanide
HCN, CNCl, NaCN, KCN
Ethylene Glycol Ethane-1,2-diol
. O H
H O
b
b-www.emolecules.com
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Ketamine,
KETANEST®,
KETASET®,
KETALAR®
2 -(2 -chlorophenyl)-
2 -(methylamino)-
cyclohexanone
Ketones Ketone group
Lamotrigine,
LAMICTAL®
3,5-diamino-6-(2,3-
dichlorophenyl)-as-
triazine
Vi
n L x p L
C f
Cl
Lead N/A Pb
Lidocaine,
LIGNOCAINE®
acetamide, 2 -
(diethylamino)-N-
(2 ,6-dimethylphenyl) N H - C O - C H 2 - K
/
1
\
C,H2*̂ 5
CoH2^5
Mercury N/A Hg
Strychnine Strychnos nux- 
vomica
b-www.emolecules.com
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